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ABSTRACT OF DISSERTATION 
 
 
 
 
ROLE OF CYCLOPHILIN D IN SECONDARY SPINAL CORD AND BRAIN 
INJURY 
 
In t he hours and days following acu te CNS i njury, a se condary wave o f 
events is initiated that exacerbate spinal tissue damage and neuronal cell death. 
A pot ential m echanism dr iving t hese se condary ev ents is opening o f t he 
mitochondrial per meability t ransition p ore ( mPTP) and su bsequent r elease of 
several ce ll deat h proteins. P revious studies have sh own t hat i nhibition of 
cyclophilin D (CypD), the ke y r egulating co mponent i n mPTP opening, w as 
protective ag ainst i nsults that i nduce ne crotic cell deat h.  We therefore 
hypothesized t hat CypD-null mice w ould sh ow i mproved functional an d 
pathological out comes following sp inal co rd i njury ( SCI) and t raumatic brain 
injury ( TBI). M oderate an d s evere sp inal co ntusion w as produced i n w ild-type 
(WT) and  CypD-null mice at  t he T -10 l evel using t he Infinite Horizon impactor. 
Changes in l ocomotor function w ere ev aluated using t he B asso Mouse Scale 
(BMS) at 3 days post-injury followed by weekly testing for 4 weeks.  H istological 
assessment o f tissue sparing and  l esion v olume w as performed 4 w eeks post 
SCI.  C alpain activity, measured by calpain-mediated spectrin degradation, was 
assessed i n m oderate i njury onl y by  western bl ot 2 4 h ours post S CI.  R esults 
showed t hat following m oderate S CI, CypD-null mice had  no si gnificant 
improvement in locomotor recovery or tissue sparing compared to wild-type mice. 
Following se vere S CI, CypD-null mice sh owed si gnificantly l ower l ocomotor 
recovery and decreased tissue sparing compared to WT mice. Calpain-mediated 
spectrin degradation was not significantly reduced in CypD-null mice compared 
to WT mice 24h post moderate SCI.  The lack of protective effects in CypD-null 
mice suggests that more dominant mechanisms are involved in the pathology of 
SCI. I n ad dition, C ypD m ay hav e a pr o su rvival r ole t hat i s dependent o n t he 
severity of the spinal cord injury.  
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Chapter One 
Primary and Secondary Pathology in Traumatic Spinal Cord and Brain 
Injury 
 
 Traumatic injury that disrupts essential neurological functions can severely 
impact the quality of one’s life.  Chronic sensory deregulation, cognitive 
dysfunction, and motor impairment are just some of the debilitating 
consequences of force induced neurological damage.  Two of the most common 
sources of neurological damage are traumatic injury to the spinal cord and the 
brain.  The pathology of these traumatic injuries can be categorized into two 
major events. The first event is the primary injury, which is defined as the initial 
mechanical damage upon the point of impact.  The second event, called 
secondary injury, occurs hours, days, and weeks following the primary injury. 
During the time course of secondary injury, there is an acceleration of tissue 
damage at the epicenter, or the point of injury, and at distal sites from the 
epicenter.  Defining these pathological events is critical when considering 
therapeutic intervention following the injury.  Unfortunately, there is little that can 
be done to intervene with the damage suffered during the primary injury, as the 
time course is too rapid for critical response.  However, events during the 
secondary injury present a window of opportunity to attenuate and prevent further 
tissue damage.  The ability for recovery from sensory and motor deficits following 
traumatic brain and spinal cord injury can be greatly enhanced by therapeutic 
intervention during the course of secondary injury.  Thus, there is a dire need for 
Introduction 
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research into the physiological and biological mechanisms that drive secondary 
injury cascades.  Uncovering the function of key pathways in secondary 
pathology can serve as the foundation for clinical treatment and recovery for 
those suffering from traumatic spinal cord and brain injury.       
    
Pathology of Traumatic Spinal Cord Injury  
Each year, approximately 7800 people suffer from a traumatic injury to the 
spinal cord in the United States (NSCISC 2009).  Though these injuries can 
occur in any age group, it is most prevalent at the ages of 16 to 30 years.  Of 
these documented cases each, motor vehicle accidents are the leading cause of 
spinal cord injury.  Other incidents, such as common falls, acts of violence, and 
sports related injuries, all contribute to spinal cord injury (Figure 1). The most 
common cause of spinal cord injury occurs from a compression and flexion of 
both the cervical and thoracic vertebra resulting in a fracturing or dislocation of 
the vertebral column (NSCISC 2009).  
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Motor 
44%
Violence
24%
Falls
22%
Sports
8%
Other
2%
Causes of Spinal Cord Injury
 
Figure 1.1 Causes of spinal cord injury in the U.S.  The leading cause of SCI 
is motor accident at 44%.  Violent assaults are next at 24% with injurious falls at 
22%.  Sports related accidents and others makeup 8% and 2% of causes of SCI.  
Chart modified from 2009 statistical data obtained from The National Spinal Cord 
Injury Association.      
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The impairments that follow spinal cord injuries stem from damaged axons 
and subsequently disruption of neurotransmission up and down the spinal cord.  
Perhaps the most notable deficit following spinal injury is loss of mobility from 
impaired neurotransmission to skeletal muscles.  There is also significant 
impairment in autonomic functions as evident by chronic sensation of pain and 
bowel and bladder dysfunction.  However, the severity of the spinal injury is often 
indicated by the extent of respiratory complications.  Significant damage to the 
diaphragm and respiratory pathway indicates a high vertebral level injury.  Spinal 
injuries that occur higher on the vertebral column, specifically at the cervical 
level, result in full or partial tetraplegia.  Damage as high as the C3 level will 
produce complete loss of motor and sensory function from the neck down with 
the requirement of a ventilator for breathing.  Injuries occurring at lower levels in 
the vertebral column, such as the thoracic level, result in paraplegia.  One may 
still have control over head, neck, and arm function, but may suffer complete loss 
of lower limb mobility and autonomic control.  
The degree of functional loss following spinal cord injuries is often 
classified as complete or incomplete injuries.  Individuals diagnosed as 
incomplete, reported as approximately 45% of all U.S. cases, will still maintain a 
degree of neurological activity below the site of injury.   Thus, motor and sensory 
function may be retained at some level, allowing for a greater recovery.  Those 
diagnosed with complete spinal injury, reported as approximately 55% of U.S. 
cases, will have a complete loss of sensory and motor function below the site of 
 5 
injury, often accompanied by chronic autonomic irregularities (Figure 1.2) 
(NSCISC 2009).   
 
Complete
45%
Complete loss 
of motor and 
sensory 
function
Incomplete
55%
Some motor 
and sensory 
Function
Injury Classification
 
Figure 1.2 Classification of spinal cord injuries since 1988.  55% of reported SCI 
cases in the U.S. result in incomplete paralysis.  45% of reported cases result in 
complete paralysis. Chart is modified from the 2009 statistical data obtained from 
The National Spinal Cord Injury Association.      
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 Primary spinal cord damage occurs from the mechanical forces upon 
initial impact that cause spinal tissue to abruptly shift, shearing neuronal and 
endothelial cell membranes (Tator and Fehlings 1991; Profyris, Cheema et al. 
2004). The shifting of tissue caudal and rostral to the epicenter, or the impact 
zone, places the greatest stress at the center of the cord (Blight et al. 1986; 
Mautes et al. 2000). This creates a unique phenomenon where vessels and 
axons localized near the surface of the cord experience little trauma. However, 
the enriched microvascular environment of the central gray matter and the axons 
located close to the gray matter experience severe stretching and shearing 
(Blight et al. 1986; Mautes et al. 2000; Young 2002).   
The central hemorrhage following damage encompasses the gray area of 
the epicenter and radiates into the surrounding white matter (Noble et al. 1989; 
Noble et al. 1996; Mautes et al. 2000).   Regions extending in the caudal and 
rostral direction from the epicenter show hemorrhagic lesion localized primarily to 
the dorsal columns (Mautes et al. 2000).  Despite the initial formation of a 
hemorrhagic lesion, there is very little gross damage to the spinal cord.  
However, during the secondary wave of injury, the hemorrhaging that occurred 
during the initial injury triggers a wave of further necrosis and apoptosis causing 
massive tissue degeneration and cellular death at and below the sight of injury 
(Tator et al. 1991). 
  In the first few hours of the secondary wave, tissue surrounding the 
primary lesion site appears pale due to edema response to injury.  This 
surrounding tissue undergoes necrosis, further expanding the lesion site evolving 
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into a cyst cavitations bordered by glial scar tissue (Guth et al. 1999; Beattie et 
al. 2002).  By the eighth week, the spinal lesion has localized to the dorsal 
columns (Guth et al. 1999; Basso et al. 2002).  The cystic lesion has now 
extended caudal and rostral to the epicenter (Profyris et al. 2004).   At the lesion 
site, there is a persistent neutrophil infiltration and glial response that prevents 
any arborization of blood vessels.  However, this event in the dorsal columns 
attenuates over the period of a week.  Macrophage presence gradually 
disappears by eight weeks and any cyst-like cavitation has receded to the rim of 
the lesion, allowing dense innervations of blood vessels and regenerated nerve 
fibers into the dorsal columns (Guth et al. 1999).   
The histopathological changes observed in the dorsal columns may stem 
from Wallerian degeneration of axons around the site of injury (Dusart and 
Schwab 1994; Guth, Zhang et al. 1999).  Following spinal trauma, axonal 
swelling and myelin rupturing continue for approximately 24 hours, expelling 
axonal debris into the extracellular space (Profyris et al. 2004).  Accumulation of 
organelles in axonal bulb has been documented, possibly due to disruption and 
blockage of axoplasma flow (Anthes et al. 1995).  Rupturing of axonal 
membranes and leakage of organelles leads to a low intra-axonal volume.  This 
low volume allows myelin to collapse upon itself resulting in axonal invagination 
(Balentine 1988; Anthes et al. 1995).  Tissue compression, red blood cell 
damage, and blood-brain-barrier breakdown within the spinal tissue creates an 
ischemic environment that is conducive to cell death (Mautes et al. 2000).   
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These waves of necrotic to apoptotic cascades proceed in a unique 
pathological track away from the site of injury. White matter, extending caudal 
from the impact site, becomes the primary target for apoptosis (Crowe et al. 
1997).  Apoptotic death not only effects neurons, but non neuronal cells, 
specifically oligodendrocytes, become a prime targets in the late stages of 
delayed death (David 2002; Profyris, Cheema et al. 2004). The loss of 
oligodendrocytes deprives neurons of trophic support resulting in impaired 
mylenation of injured axons.  Another devastating consequence of 
oligodendrocyte death is the loss of spared, healthy axons around the injury site 
and in remote areas (Blight et al. 1986; Crowe et al. 1997). Subsequently, both 
ascending and descending axons undergo Wallerian degeneration of axons, a 
process in which axonal cytoskeleton disintegrates and disruption of the axonal 
membrane (David 2002; Profyris et al. 2004).  
 
Pathology of Traumatic Brain Injury  
In the United States of America, there is an estimated 1.5 million head 
injuries each year (braintrauma.org, CDC 2007).  Traumatic brain injury is the 
leading cause of death in children and adults with approximately 52,000 deaths is 
the result from a sudden trauma to the head (Rutland-Brown et al. 2006; 
Prevention 2007).  Some of the most common causes of head trauma are falls, 
motor crashes, and sports injuries (Figure 2) (Langlois et al. 2006; Prevention 
2007). In addition, traumatic brain injuries have become a critical concern 
amongst active duty soldiers serving in war zones.   It was reported by Veteran’s 
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advocates that an estimated 10 to 20% of Iraqi veterans display some gradient of 
brain injury (Prevention 2007).  
Falls
36%
Motor
26%
Blunt Strike
24%
Assault
14%
Causes of Traumatic Brain Injury
 
Figure 2  Causes of Traumatic Brain Injury in the United States.  Approximately 
36% of all TBI cases in the U.S. result from common falls.  Motor accidents make 
up 26% of all reported TBI cases.  Blunt strikes to the head make up 24% of all 
TBI ca ses while 14%  o f all TBI ca ses r esult from v iolent assaults.  G raph 
modified from 2007 statistical data collected by the The CDC National Center for 
Injury Prevention and Control. 
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The forces that damage the brain can range from a focal contusion, 
directional acceleration and deceleration of the cranium, or blast-induced 
concussions. Focal contusion based injuries are the result of a blunt force directly 
to the cranium.  With focal contusion, there may be a fracturing of the skull, 
tissue deformation, vascular disruption and subsequent hemorrhaging (Gaetz 
2004).  However, a direct force to the head is not necessary for producing TBI. 
The sheering forces from violent head movement throughout space can produce 
severe brain injury (Ommaya et al. 1974; Varney et al. 1995; Gieron et al. 1998).  
Forceful motion of the head in a rotational or forward and backward motion 
induces a sheering of blood vessels and neuronal components (Ommaya et al. 
1974; Gaetz 2004).  The initial impact produces an injury gradient with damages 
seen at cortical levels and, depending on severity, spreading throughout 
subcortical areas (Pettus et al. 1994; Gaetz 2004).  Severe blasts, such as that 
induced by high powered weapons or explosives, produces dramatic pressure 
changes causing rupturing and shearing of organs with tertiary damage caused 
by propagation of the blast wave throughout the body (Mayorga 1997; Elder and 
Cristian 2009).  
 The observable symptoms of any trauma to the head range from mild to 
severe.  Mild symptoms include headache, confusion, fatigue, and blurred vision. 
More sever symptoms includes convulsions, numbness in the extremities and 
loss of consciousness.  The focus of this chapter will emphasize focal contusion 
pathology, as the model used for experimentation is contusion-induced brain 
deformation.   
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A pathological hallmark in acute brain contusion is vascular damage from 
deformation of the skull  (Davis 2000).  Hemorrhagic lesions following contusion 
are classified as extradural and intradural hematomas (Davis 2000).  Extradural 
hematomas are caused by the fracturing of the skull with subsequent shearing of 
dural matter directly beneath the skull along with the vasculature network (Davis 
2000).  Intradural hematomas can occur without fracturing of the skull and are 
typically induced by the acceleration and deceleration of the brain from 
contusions and are more indicative of secondary or delayed damage (Davis 
2000).  Occlusion of subdural veins from dramatic shifting forces is a hallmark of 
an intradural injury called subdural hematoma.  Another form of intradural injury 
is intracerebral hemaetoma, characterized as a collective swelling or clotting from 
extending into white matter, corpus callosum, and basal ganglia (Davis 2000).  
Auto regulation of cerebrovascular flow is critical for vascular dilation and 
constriction in response to cranial pressure (Werner et al. 2007).  Primary 
mechanical damage often leads to impaired auto regulation of cerebrovascular 
flow, creating an ischemic like environment (Hermanns et al. 2001).   
Vascular damage is the primary pathological outcome seen in the initial 
stages of brain injury. The ischemic environment created by the initial vascular 
damage triggers further waves of deleterious events.  Peripheral damage may be 
initiated from peri-infarct depolarization, a global depolarization phenomenon 
occurring in both neuronal and glial cells in the penumbra (Nedergaard 1988; 
Church and Andrew 2005). Cortical spreading depression (CSD), though typically 
not involved in tissue damage, may actually contribute to additional cell loss 
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following contusion as observed in recent electrophysiological studies (Church 
and Andrew 2005; Fabricius, Fuhr et al. 2006; Hartings, Gugliotta et al. 2008).   
In TBI, secondary neurodegeneration has been reported in several areas 
adjacent to and quite distal from the impact site following experimental brain 
injury (Hall et al. 2005; Hall et al. 2008).   Depending on the severity of injury, 
tissue damage may be observed in sub regions of the hippocampal formation, 
the thalamus, and dorsal regions of the striatum over a 48 hour period (Dixon, 
Kochanek et al. 1999; Hall, Sullivan et al. 2005; Hall, Bryant et al. 2008).  
Extensive axonal damage has also been documented in sub regions of the 
hippocampus, the internal capsule, thalamic nuclei, and as distal as regions in 
the cerebellum and brain stem (Lighthall et al. 1990; Hall et al. 2005).  These 
observations were reported at later times, from 24 hours to 7 days, following 
cortical contusion suggesting a diffuse mechanism of axonal degeneration that is 
characteristic of secondary pathology (Lighthall, Goshgarian et al. 1990; Hall, 
Sullivan et al. 2005). Mechanisms contributing to these secondary events will be 
discussed in greater detail below. 
Following TBI, the ischemic environment from vascular damage gives way 
to the secondary cascade of cellular damage triggered by abnormal levels of 
extracellular glutamate (Arundine and bTymianski 2004; Gaetz 2004).  As 
discussed earlier, massive depolarization and subsequent Ca2+ homeostasis 
disruption propagate a cycle of secondary cell death (Choi 1988; Fiskum 
2000; White, Sullivan et al. 2000; Arundine and Tymianski 2004; Gaetz 2004).        
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Cell Death in Traumatic Spinal Cord and Brain Injury 
 This introduction has so far discussed much of the vascular damage from 
primary injury and the spatial and temporal characteristics of tissue damage from 
secondary damage. A more detailed discussion of the cellular events effected 
and contributing to secondary damage is critical as it emphasizes key 
mechanism targeted by current therapeutic drugs.  Though, both necrotic and 
apoptotic events are apparent during secondary damage, the distinction is more 
complex than often reported as both events can occur in parallel within the same 
cell (Gaetz 2004).    
The history of excitotoxicity by various excitatory amino acids has long 
been established as detrimental force in neuronal death.  Glutamate, specifically, 
has shown to be intensely involved in acute and delayed neurological trauma 
(Olney 1971; Choi 1988; Goldberg, Monyer et al. 1988; Panter, Yum et al. 1990; 
Arundine and Tymianski 2004).  Massive depolarization, often in response to the 
ischemic environment induced from primary damage, triggers further neuronal 
glutamate release, leakage of intracellular glutamate, and dysfunctional 
glutamate uptake (Mills, Fullwood et al. 2001; Arundine and Tymianski 2004; 
Gaetz 2004).  Collectively, these events propagate a detrimental loop of 
glutamate release and autocrine-like stimulation of the same cell.  Furthermore, 
abnormal levels of extracellular glutamate stimulate and release inhibition of 
glutamate-specific channels, specifically N-methyl-D -aspartate (NMDA), α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (Kwong et al.) and kainite 
(Doble 1999; Profyris, Cheema et al. 2004).  What follows is further disruption in 
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ionic balance by large influxes of Na into the cell (Doble 1999; Profyris, Cheema 
et al. 2004) . The cell is now subjected to increased water influx and the fatal 
occurrence of cell lysis (Doble 1999; Profyris, Cheema et al. 2004).  It is a 
collective effort of ion imbalance that triggers disruption of a cell’s intrinsic 
machinery. However, elevated Ca2+ in both the extracellular and intracellular 
environment has historically been the subject of intense research in the field of 
brain and spinal trauma (Maynard et al. 1977; Happel et al. 1981; Banik et al. 
1984; Seliger et al. 1989; Gelderd et al. 1990; Moriya et al. 1994; Kampfl et al. 
1996; Rzigalinski et al. 1998; Weber et al. 1999; Bondarenko et al. 2001; Farkas 
et al. 2005; Nehrt et al. 2007).   
The massive depolarization observed in secondary injury is accompanied 
by large influxes of Ca2+ through voltage gated Ca2+ channels (Profyris et al. 
2004).  Inside the cell, increasing Ca2+ concentrations actually mobilizes 
intracellular stores of Ca2+ that activate several deleterious Ca2+ dependent 
enzymes and disrupt mitochondrial function (Banik, Hogan et al. 1982; Moriya, 
Hassan et al. 1994; Doble 1999; Sullivan, Krishnamurthy et al. 2007).  Perhaps 
the seminal event in death of neurons and non neuronal cells during secondary 
neurological injury is Ca2+ induced permeability of the mitochondria.   The 
following section will address the role of mitochondria in cell vitality and how the 
influx of Ca2+ following injury can compromise mitochondria function.  
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Mitochondrial Dysfunction in Traumatic Spinal Cord and Brain Injury 
Survival and development of all cells is largely dependent on the 
bioenergetics of the mitochondria.  These powerhouse structures are critical in 
the metabolism of energy sources and feature apoptotic pathways involved in 
development and cellular trauma (Fiskum 2000; Wieloch 2001; Sullivan, 
Rabchevsky et al. 2005).  Much of neuronal activity, such as the demanding 
plasma ion pumps, is almost exclusively dependent on adenosine triphosphate 
(ATP).  Tissue stores and anaerobic glycolysis only provide brief supplies ATP.  
However, the mitochondria, through breakdown of its dominant substrate 
pyruvate, is able to generate a rapid and abundant supply of ATP and ATP 
turnover is the mediating factor in mitochondrial respiration(Budd and Nicholls 
1998; Nicholls and Ward 2000).  Mitochondria are also critical to neuronal 
function due to their ability to sequester calcium ions, a function critical during 
neuronal hyperactivity (Ichas and Mazat 1998; Rizzuto, Pinton et al. 1999; 
Nicholls and Ward 2000).  Under physiological conditions, transport of Ca2+ into 
the mitochondria is dependent on the presence of an electrogenic transporter, 
the Ca2+ uniporter, as opposed to dependence on ATP hydrolysis (Ichas and 
Mazat 1998; Rizzuto, Pinton et al. 1999; Bano, Young et al. 2005).  The Ca2+ 
uniporter facilitates ion diffusion in the direction of its electrochemical gradient.  
This calcium release is facilitated by exchange with the Na+/ Ca2+ antiporter.  
Together with the Na+/H+ antiporter, a slow, continuous cycling of Ca2+ across the 
mitochondrial inner membrane is established (Crompton et al. 1998; Crompton 
1999; Sullivan et al. 2005).  Increases in cytosolic Ca2+ can trigger further release 
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of Ca2+ from neuronal intracellular compartment known as the smooth 
endoplasmic reticulum.  Ryanodine receptors, located on smooth endoplasmic 
reticulum, and the second messenger metabolite innositoltriphosphate3 are 
sensitive to intracellular calcium levels and respond by releasing stored calcium 
(Bardo et al. 2006).  This excessive rise in intracellular Ca2+ can compromise 
mitochondrial function (Nicholls 1978; Crompton 1999).  Pathological conditions 
can facilitate large increases in extracellular Ca2+, ultimately leading to 
mitochondrial matrix Ca2+ overload and subsequent increased mitochondrial 
permeability (mPT) (Hunter, Haworth et al. 1976; Hunter and Haworth 1979; 
Szabo and Zoratti 1992; Bernardi and Petronilli 1996).  
 
Mitochondrial Permeability Transitional Pore 
Mitochondrial permeability (mPT) is defined as a rapid increase in the 
permeability of the inner mitochondrial membrane space to solutes with 
molecular masses less than 1500 Daltons (Hunter and Haworth 1979; Nicolli, 
Basso et al. 1996; Sullivan, Rabchevsky et al. 2005). Increased permeability of 
the mitochondria results in a swelling phenomenon. Crompton and colleagues 
attributed this swelling to a high concentration of protein debris left in the inner 
membrane following passage of solutes (Crompton 1999; Halestrap, McStay et 
al. 2002).  Early studies hypothesized that mitochondrial invertebrate 
permeability was another means of Ca2+ transport, specifically an ionic efflux 
mechanism (Gunter et al. 1990).  However, extensive studies revealed this not to 
be the case as the increased permeability was due to the formation of a 
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nonselective megachannel (Bernardi and Petronilli 1996; Sullivan, Rabchevsky et 
al. 2005).  Furthermore, unregulated opening of this megachannel, termed the 
mitochondrial permeability transition pore (mPTP), was found to be a driving 
mechanism behind apoptotic and necrotic cell death (Szabo and Zoratti 1991; 
Szabo and Zoratti 1992; Crompton 1999; Shimizu, Narita et al. 1999; Fiskum 
2000).  Formation and opening of the mPTP trigger a series of detrimental events 
that ultimately disrupt mitochondria bioenergetics (Figure 2).  This is a 
pathological hallmark of necrotic cell death, such as that observed under periods 
of ischemia/reperfusion (Kerr, Suleiman et al. 1999; Kim, He et al. 2003; Leung, 
Varanyuwatana et al. 2008).   
 
 
 18 
 
Figure 3 Simplified illustration of mPTP complex.  CypD binds to the ANT/VDAC  
complex initiating mPTP formation and release of µ-calpain, AIF, and EndoG. CsA 
inhibits CypD binding and subsequent mPTP formation.  Diagram courtesy of Dr. 
James Geddes.  
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Swelling of the mitochondrial IMM and subsequent membrane 
permeability results in decay of the inner membrane potential and subsequent 
uncoupling of the electron transport system.  Dramatic increases in Ca2+  
concentrations give rise to reactive oxygen species (ROS), exposing the electron 
transport chain to free radicals that disrupt oxidative phosporylation. This 
breakdown of oxidative phosphorylation actually leads to hydrolyses of ATP by 
reversal of ATPase, the enzymatic machinery responsible for translocating 
protons across the inter-membrane (Szabo, Bernardi et al. 1992; Zoratti and 
Szabo 1995; Halestrap, Clarke et al. 2004; Forte, Gold et al. 2007).  Ultimately, 
there is a decrease in ATP production as a result of adenine nucleotide depletion 
along with increased phosphate, and subsequently pH (Fiskum 2000; Halestrap, 
Clarke et al. 2004).  These events sensitize the opening of the mPTP which 
mediates further cell damage by release of several degrading enzymes (Ding, 
Shen et al. 2002; Ferrand-Drake, Zhu et al. 2003; Kim, He et al. 2003).   
mPTP formation and opening has also been implicated in apoptosis.  
Recent reports have suggested that mPTP can transition from necrotic induced 
cell death to a mediator of apoptotic pathways (Kim, He et al. 2003; Kim, He et 
al. 2003).  Apoptotic stimuli, such as members of the pro apoptotic family of Bcl-2 
stimulate opening of the mPTP (Crompton 1999; Kroemer and Reed 2000; 
Halestrap, McStay et al. 2002).  The increased permeability of the mitochondrial 
outer membrane permits release of such apoptotic factors as cytochrome C, 
apoptosis inducing factor (AIF), and Smac/Diablo from the mitochondrial inter-
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membrane (Crompton 1999; Annis, Zamzami et al. 2001; Halestrap, McStay et 
al. 2002).   
The emerging role of mPTP in pathological events produced an intensive 
search for the components that constitute the megachannel.  The three best 
characterized components to date are the adenine nucleotide translocase, the 
voltage dependent anion channel, and cyclophilin D.  Though recent reports have 
uncovered a more complex makeup of the mPTP than originally documented, the 
following section will review the three basic components mentioned above.  
 
The adenine nucleotide translocase (ANT) is a 30 kDA protein located 
exclusively to the inner membrane of the mitochondria (Brustovetsky and 
Klingenberg 1996; Crompton, Virji et al. 1998; Vieira, Haouzi et al. 2000).  The 
ANT exhibits many operations characteristic of the mPTP.  Upon exposure to 
high concentrations of Ca2+, the ANT undergoes a conformational change from a 
selective antiporter to a nonselective pore (Brustovetsky and Klingenberg 1996; 
Crompton 1999). (Crompton, Virji et al. 1998; Crompton 1999). (Al-Nasser et al. 
1986).  The normal role of the ANT is the translocation of adenine nucleotides, 
specifically, ATP and ADP across the inner mitocondrial membrane, which 
serves as a proton-driven co-transport.  This translocation of ATP and ADP allow 
for charge compensation to the calcium mediated increase in matrix volume, an 
effect by K+ and subsequent water entry (Haworth and Hunter 1980; Halestrap, 
McStay et al. 2002).  Nucleotides that interact with ANT are limited to only ADP, 
dADP, and ATP and when bound in the c-sate, induce an active channel 
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conformation (Woodfield, Ruck et al. 1998).  Recently, it has been documented 
that a range of pro-apoptotic proteins are able to bind to ANT, including Bcl-2 and 
Bax (Marzo, Brenner et al. 1998). Previously research has shown that Bax 
binding cooperates in mPTP opening (Marzo, Brenner et al. 1998; Kowaltowski 
2000).  In addition, cells over expressing Bcl-2 allowed for greater mitochondrial 
Ca2+ capacity, attenuation in mitochondrial membrane potential, and generation 
of a higher reduction state, opposing the increases oxidative state induced by 
mPTP opening (Murphy, Bredesen et al. 1996; Vieira, Haouzi et al. 2000). While 
these characteristics demonstrate that ANTs are crucial in mPTP formation, 
recent literature has demonstrated that mPTP is still functional in ANT knock out 
models (Kokoszka et al. 2004). Thus, other components forming the mPTP were 
investigated to determine those critical in pore regulation. 
  
Voltage Dependent Anion Channel (VDAC). The release of apoptogenic factors, 
such as cytocrome C and AIF, from mitochondria demonstrate increased 
permeability of the outer membrane (Priault, Camougrand et al. 1999; Tsujimoto 
and Shimizu 2000).  It is now widely accepted that pro-apoptotic members of the 
Bcl-2 family can directly control mitochondrial permeability during apoptosis 
(Priault, Chaudhuri et al. 1999; Shimizu, Narita et al. 1999; Tsujimoto and 
Shimizu 2000).  Further investigations showed a highly conserved barrel protein 
spanning the outer membrane, the voltage dependent anion channel (VDAC), 
that serves as a mitochondrial highway for all entering and exiting metabolites 
(Lemasters et al. 2006).  The channel is voltage dependent in that both positive 
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and negative potentials close the channel.  VDAC also demonstrates ion 
selectivity when in an open conformation (Colombini 1983; Lemasters and 
Holmuhamedov 2006).   
Open conformation of the VDAC is critical for release and uptake of 
respiratory substrates, specifically ATP and ADP that facilitate mitochondrial 
function (Vander Heiden, Li et al. 2001).  As discussed earlier, interaction of 
proapoptotic factors with VDAC facilitates mitochondrial dysfunction.  Recent 
reports revealed that interaction of pro-apoptotic Bcl members close VDAC, 
prohibiting mitochondrial respiration (Vander Heiden, Li et al. 2001).  VDAC 
closure leads to increased outer membrane permeability and translocation of 
cytochrome c (Rostovtseva, Antonsson et al. 2004).   These events can occur 
either independently or collectively with mitochondrial inner membrane 
permeability and subsequent collapse of membrane potential (Priault, 
Camougrand et al. 1999; Tsujimoto and Shimizu 2000).  Though several reports 
have implicated VDAC in apoptotic induced mitochondrial dysfunction, there is 
still uncertainty in its involvement in mPTP formation.  Similar to ANT, knock-out 
models of VDAC did not affect mPTP formation and VDAC closure does not 
attenuate Ca2+ flux (Basso, Fante et al. 2005; Rostovtseva, Tan et al. 2005).  
Further investigations into a mediating component of the mPTP unveiled a 
potential candidate from cyclophilin family called cyclophilin D (cypD). 
 
Cyclophilin D.  It was discovered that opening of the mPTP could be inhibited 
specifically by sub-micro molar concentrations of the immunosuppressive drug, 
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cyclosporin A (CsA)(Crompton, Ellinger et al. 1988; Nicolli, Basso et al. 1996; 
Kowaltowski, Smaili et al. 2000).  Specifically, these early studies revealed that 
CsA inhibited the activities of peptidyl-prolyl-cis-trans-isomerase (PPIase) located 
in the mitochondria matrix (Crompton et al. 1988).  This PPIase was identified as 
CypD (Crompton et al. 1988).   
Cyclophilins display catalytic properties by refolding denatured proteins 
and importing the reconformed proteins into organelles, as evident by a retarded 
rate of protein folding in cyclophilin mutant yeast mitochondria (Lin, Hasumi et al. 
1988; Lithgow, Horst et al. 1995; Matouschek, Rospert et al. 1995).  In addition, 
cyclophilins are recruited to fully functional protein complexes (Wu, Matunis et al. 
1995; Crompton, Virji et al. 1998; Jaschke, Mi et al. 1998).  Several reports 
showed that CypD binds to the ANT/VDAC complex, confirming CypD as a 
component for mPTP configuration (Crompton, Virji et al. 1998; Woodfield, Ruck 
et al. 1998; Halestrap, McStay et al. 2002; Leung and Halestrap 2008; Leung, 
Varanyuwatana et al. 2008).  Evidence points to CypD’s catalytic properties as a 
potential mechanism for proper folding of pore component aggregates, resulting 
in mPTP formation (Connern and Halestrap 1994; Connern and Halestrap 1996; 
Leung, Varanyuwatana et al. 2008).  It is important to note that new research 
suggest that another pore component consisting of a phosphate carrier, PiC, is 
the primary target of CypD induced conformational change as opposed to ANT 
(Leung et al. 2008).  This demonstrates the ever emerging complexity of the 
mPTP.   
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Both pharmaceutical inhibition of CypD and knock out of the CypD gene 
Ppif have shown modest protection in animal models of neurotrauma.  CsA and 
its analog NIM811 showed modest improvement in tissue and behavioral 
assessment following traumatic brain injury and spinal cord injury (Sullivan, 
Rabchevsky et al. 2000; McEwen, Sullivan et al. 2007; Ravikumar, McEwen et al. 
2007; Mbye, Singh et al. 2008).  Other pathological states, such as muscle 
dennervation, multiple sclerosis, and oxidative induced hippocampal damage, all 
illustrated the role of CypD as a potent mediator of cell damage (Khaspekov, 
Friberg et al. 1999; Csukly, Ascah et al. 2006; Forte, Gold et al. 2007).  However, 
the protective effects produced from CypD inhibition are not universal to all 
deleterious pathways.  Several reports have shown that the efficacy of targeting 
CypD may only be protective under necrotic events.  Cell death induced by 
reactive oxygen species or Ca2+  overload, such as that observed in ischemic 
conditions, was attenuated by CypD ablation (Baines, Kaiser et al. 2005; 
Nakagawa, Shimizu et al. 2005; Schneider 2005).  Apoptotic stimuli, such as 
members of the Bcl-2 family, induce cell death regardless of CypD inhibition 
(Baines, Kaiser et al. 2005; Basso, Fante et al. 2005; Nakagawa, Shimizu et al. 
2005).   
 
Calpain and Traumatic Spinal Cord and Brain Injury 
The disruption of Ca2+ homeostasis and subsequent mitochondrial 
function can unleash a host of enzymatic activity that further mediates cell 
damage.  MPTP opening is a driving force behind necrotic death, however, 
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closure of this channel may only divert the necrotic pathway to apoptosis 
(Nicotera and Leist 1997; Halestrap, McStay et al. 2002).   Increased 
permeability of the outer membrane allow leakage of inner membrane factors 
such as apoptosis inducing factor (AIF), cytochrome c, and Smac/Diablo 
(Kroemer and Reed 2000; Loeffler, Daugas et al. 2001; Halestrap, McStay et al. 
2002; Ferrand-Drake, Zhu et al. 2003).  Additionally, members of the cysteine 
protease family are also activated and mobilized.  Caspases mediate apoptosis 
by disruption of DNA repair, mRNA splicing, and cytoskeletal breakdown and 
reorganization (Kermer, Klocker et al. 1999; Kermer, Klocker et al. 1999).  Other 
members of the cysteine protease family are Ca2+ activated proteolytic enzymes 
called calpains.  The following section will discuss in greater detail the structure 
and physiological functions of calpains. 
To date,  approximately 15 calpain isoforms have been identified in 
humans.  The typical calpains are ubiquitously expressed while atypical calpains 
are tissue specific (Goll et al. 2003). Many of these isoforms have prominent 
roles in such pathological conditions as diabetes, muscular dystrophy, and brain 
and spinal injury (Banik, Shields et al. 1998; Huang and Wang 2001; Zatz and 
Starling 2005; Deng, Thompson et al. 2007; Liu, Liu et al. 2008).  Two of the 
most extensively characterized isoforms are the typical calpains µ-calpain and m-
calpain.  The classifications are based on their large catalytic subunits calpain 1 
and calpain 2 (Goll et al. 2003; Bevers et al. 2007). In addition to their distinct 
catalytic subunits, these two isoforms share a common regulatory small subunit 
(Cong et al. 1989; Bevers et al. 2007).  Both isoforms are regarded as cytosolic 
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enzymes, though recently µ- calpain was found to be expressed in the 
mitochondria inner membrane (Badugu et al. 2007).  One of the distinguishing 
characteristics amongst µ-calpain and m-calpain is the concentrations of Ca2+ 
required for activation (Goll et al. 2003).  For example, m-calpain requires 
approximately 1 to 20um concentration whereas 250 to 750um concentration of 
Ca2+ are required for µ-calpain (Zimmerman et al. 1984; Goll et al. 2003; Li et al. 
2004). 
 Several proteins are substrates for calpains such as cytoskeletal 
structural proteins, cell motility proteins, and calcium dependent enzymes 
(Posmantur et al. 1994; Pang et al. 1996; Azam et al. 2001). Both µ-and m-calpain 
undergo autolysis in the presence of Ca2+ (Cong, Goll et al. 1989; Edmunds, 
Nagainis et al. 1991; Saido, Nagao et al. 1992).  SDS-PAGE revealed that 
autolysis of both calpain isoforms resulted in a reduced mass of the 80 kDa 
subunit to 76 kDa and the 28 kDa subunit to 18 kDa (Graham-Siegenthaler et al. 
1994).  As a result of calpain autolysis, specifically the large subunit, the Ca2+ 
concentration for half-maximal proteolytic activity is reduced with no 
consequential affect of enzyme specificity (Edmunds, Nagainis et al. 1991; Goll, 
Thompson et al. 2003; Li, Thompson et al. 2004).  Calpains can function under a 
controlled state during normal physiological events.  Calpain targets several 
substrates for enzymatic degradation such as cytoskeletal structural proteins, cell 
motility proteins, and other calcium dependent enzymes.  For example, calpain 
mediated degradation of spectrin, a cytoskeleton protein, allows for synaptic 
 27 
remodeling, a critical function in long term synaptic potentiation and memory 
storage (Luscher et al. 2000; Liu et al. 2008).  
Calpain can be endogenously regulated by Calpastatin (Emori et al. 1987; 
Murachi 1989; Wendt et al. 2004).  Calpastatin has multiple inhibitory domains 
and is capable of  binding to several molecules of calpain in a Ca2+ dependent 
manner. (Wendt et al. 2004).  The Ca2+ requirement for endogenous inhibition is 
less than that for calpain activation (Kapprell et al. 1989; Wendt et al. 2004).  
However, under pathological conditions, calpastatin inhibition is reversible and 
can lead to unregulated activation of calpain (Arrigoni et al. 1991; Springer et al. 
1997; Tidball et al. 2002; Crocker et al. 2003; Bevers et al. 2007).   
The dramatic increase in Ca2+ due to excitotoxic events may lead to a 
sustained activation of calpain. Neuronal cell bodies and dendrites consist of a 
vast network of microtubules, which maintain morphological stability.  One of the 
critical proteins that constitute the microtubule structure is microtubule-
associated protein (MAP-2).   MAP-2 is highly susceptible to calpain degradation 
(Saatman et al. 1998; Goll et al. 2003; Liu et al. 2008).  Post synaptic bulbs and 
axonal components are also vulnerable to calpain degradation.  Alpha-II spectrin 
and neurofilaments (NF) are enriched in the axonal and post synapse 
cytoskeleton.  Both of these proteins are also substrates of calpain (Dutta et al. 
2002; Goll et al. 2003).  Further perpetuating the detrimental cycle of excitoxicity 
is calpain’s targeting of glutamate receptors.  Cleavage and subsequent 
truncation of several of the ionotropic receptors allows for further uncontested Ca 
entry into the cell (Minger et al. 1998; Simpkins et al. 2003). 
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 Elevated calpain activity has been well documented as major contributor 
to secondary tissue damage in both spinal cord and brain injury.  In spinal cord 
injury,  early  research, especially that of Banik and colleagues showed that 
calpain activity induces much of the structural damage in cell bodies and axons 
following spinal injury (Banik et al. 1998). These studies demonstrated that a 
calcium activated proteinase contributed to early losses in neurofilament proteins 
followed by granular axonal degeneration and myelin loss at later time points 
following spinal cord lesion (Banik, Hogan et al. 1982; Banik, Hogan et al. 1984; 
Banik, McAlhaney et al. 1985).  Likewise, early studies characterized localization 
of calpain-1 and calpain-2 isoforms in brain regions that are highly susceptible to 
degeneration (Siman et al. 1985; Simonson et al. 1985; Hamakubo et al. 1986).     
Calpain has since become a promising target for attenuation of secondary 
damage in spinal cord injury.  A study by Springer et al., showed that 
pretreatment with Riluzole, an inhibitor of glutamate release, reduced loss of 
MAP2 levels in rats following spinal injury (Springer et al. 1997).  Several classes 
of calpain inhibitors have provided modest protection when administered either 
pre injury or post injury.  Calpeptin, CEP-4143, and MDL-28170, are some of the 
calpain inhibitors that demonstrated potential therapeutic effects.(Ray, Shields et 
al. 1999; Schumacher, Eubanks et al. 1999; Schumacher, Siman et al. 2000; 
Zhang, Bondada et al. 2003; Yu and Geddes 2007).   CEP-4143 demonstrated 
calpain isoform specificity in its ability to target µ- calpain.  Morphometric 
assessment of tissue sparing, survival of neurons in the red nucleus, and 
behavioral deficits were protected or improved when rats were pretreated with 
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CEP-4143 (Schumacher, Siman et al. 2000).  Studies using single and sustained 
administration of MDL28170 showed improvements in tissue sparing and motor 
behavior (Hung, Hwang et al. 2005; Yu and Geddes 2007). Although not 
discussed here in detail, calpain has also been implemented in secondary 
damage following traumatic brain injury (Posmantur et al. 1994; Farkas et al. 
2005; Liu et al. 2006; Thompson et al. 2006; Deng et al. 2007).   
 30 
Injury
Vascular Damage
Ischemia
Depolarization
Increased Glutamate 
Release
mPTP Formation
Mitochondria 
Ca++ Overload
Apoptogenic
Proteins
Calpain
Activation
Ca++ Influx
ETS 
Uncoupling
Membrane 
Potential Collapse 
Decrease
ATP
Mitochondria Permeability
Cell Death
 
Figure 4.1. Simplified model of secondary injury cascade following traumatic 
spinal cord and brain contusion.  Ischemic conditions can lead to Ca2+ induced 
mPTP formation and a compromise of mitochondrial function.  
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The centralized hypothesis of the current study is that cyclophilin D null 
mice (CypD-null) will show improved pathological outcomes following spinal cord 
and cortical contusion.  Previous literature has shown that pharmacological 
inhibition of CypD improved pathological outcomes in rodent models of cortical 
contusion.  However, the protective effects of CypD have produced confounding 
results following spinal cord contusion.  Thus, it is uncertain if these 
discrepancies are due to variances in pharmacological properties or regional 
variations in the actions of CypD.  By utilizing mice with a homozygous knockout 
of CypD (encoding gene Ppif), we can directly assess the role of CypD in 
secondary spinal and cortical injury.  Our working model for the centralized 
hypothesis is that ablation of CypD will attenuate formation of mPTP formation, 
ultimately improving motor impairments, tissue sparing, and proteolytic enzyme 
activation induced by secondary damage that follows the both spinal cord and 
cortical contusion (Figure 4.2).  To test our hypothesis, we constructed the 
following specific aims: 
 
Specific Aim One will test the hypothesis that CypD-null mice will show 
improved motor function recovery following spinal contusion.  The Basso Mouse 
Scale will be used to assess changes in open field motor function. 
Specific Aim Two will test the hypothesis that CypD-null mice will show 
increased tissue sparing following spinal contusion and cortical contusion.  
Histological assessment of total spared tissue, white matter, grey matter, and 
lesion volume will be determined. 
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Specific Aim Three will test the hypothesis that CypD-null mice will show 
decreased calpain activity following spinal contusion and cortical contusion.  
Western Blot analysis of calpain-mediated spectrin metabolism will be used to 
determine calpain activity.  
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Figure 4.2 Simplified Model of the central hypotheses.  This model hypothesizes 
that CypD knockout attenuates Ca2+ induced mPTP formation following 
secondary damage 
Copyright © Jordan Clark 2009 
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Chapter Two 
 The Role of Cyclophilin D in Secondary Spinal Cord Injury 
The initial impact from traumatic spinal cord injury (SCI) can produce 
catastrophic mechanical damage.  However, in the ensuing hours and days 
following the initial impact, a secondary wave of insults is initiated accelerating 
tissue destruction several segments below the epicenter.  This secondary 
phenomenon is defined by disruption of Ca2+ homeostasis, free radical 
production, and activation of necrotic and pro apoptotic cascades (Panter et al. 
1990; Moriya et al. 1994; Popovich et al. 1996).   The time line for secondary 
injury presents a critical window for any therapeutic attempt to recover motor and 
sensory function.  A prominent driving mechanism of secondary tissue 
degradation is an increase in mitochondrial permeability to any molecules < 1500 
daltons (Hunter et al. 1976; Al-Nasser et al. 1986).  The increase in mitochondrial 
permeability causes massive swelling and disruption of the mitochondrial 
membrane, uncoupling of oxidative phosphorylation in the electron transport 
chain and subsequent down regulation of ATP production (Hunter et al. 1976; 
Bernardi et al. 1996; Crompton 1999; Halestrap et al. 2002).   
Introduction 
Though primarily driven by large influxes of Ca2+, it is the collective actions 
of secondary insults that initiate the formation of a regulated, non-specific 
megachannel within the mitochondria called the mitochondrial permeability 
transition pore (mPTP) (Szabo et al. 1992; Bernardi et al. 1996; Bernardi et al. 
1998; Crompton 1999; Sullivan et al. 2005; Smith et al. 2008).  Ultimately, it is 
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the formation of the mPTP that permits excessive ion permeability and disruption 
of mitochondrial bioenergetics (Hunter et al. 1976; Al-Nasser et al. 1986).  The 
most characterized components of the mPTP include an outer membrane 
component called the voltage dependent anion channel (VDAC) and the adenine 
nucleotide translocase (ANT), which forms the inner membrane pore, both are 
integral in mPTP formation, but are not a necessity in mPTP function (Bauer et 
al. 1999; Gross et al. 2000; De Giorgi et al. 2002; Kokoszka et al. 2004; Baines 
et al. 2005).  A critical finding by Crompton and colleagues was the inhibition of 
Ca2+ dependent mPTP opening by the immunosuppressive drug cyclosporine A 
(CsA)(1988).  Cyclosporine A mediates its actions by binding to and inhibiting the 
mitochondrial matrix component cyclophilin D (CypD) from binding to ANT 
(Crompton et al. 1998).  CsA inhibited pore formation and subsequent 
mitochondrial permeability, prompting the hypothesis that CypD is the regulating 
component in mPTP formation (Crompton et al. 1988; Connern et al. 1994; 
Crompton et al. 1998; Hansson et al. 2004).   
CypD has since shown promise as a viable target for neurotrauma 
protection.  Recent reports demonstrated the ability of cyclosporine A and its 
analog NIM811 to attenuate cortical damage in rodent models of TBI (Sullivan et 
al. 2000; Mbye et al. 2008).  However, administrations of these compounds in 
SCI models have produced confounding results. CsA has not offered the same 
extent of protection in SCI as seen in TBI, except in doses that are highly toxic 
(Rabchevsky et al. 2001; Morota et al. 2007).  NIM811 did offer moderate 
protection at the cellular level and in functional outcome following SCI at safe 
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doses (McEwen et al. 2007; Ravikumar et al. 2007).  Thus, the question remains 
as to whether these discrepancies are due to variances in pharmacological 
properties or regional variations in the components and behavior of the mPTP. 
The recent availability of transgenic mice with knockout of the CypD-
encoding gene Ppif has provided a unique opportunity to directly examine the 
role of CypD in secondary SCI and TBI damage. We used these models to test 
the overall hypothesis that ablation of CypD in mice will result in attenuation of 
secondary injury in both spinal cord contusion and cortical contusion.  Functional 
recovery was assessed by measuring recovery of hind limb motor skills over a 4 
week period.  To assess the extent of tissue sparing, we employed a modified 
eriochrome cyanine staining.  Finally, calpain activity was measured according to 
the metabolism of spectrin as determined by western blot.  The results of our 
studies show that homozygous knockout of CypD in mice offered no pathological 
improvements and some cases worsened outcomes following spinal cord 
contusion.     
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Animals.  All animals were housed in the Division of Laboratory Animal 
Resources sector of the University of Kentucky Medical Center, which is fully 
accredited by AAALAC. All experimental procedures abide by protocols approved 
by the University of Kentucky's Institutional Animal Care and Use Committee.  
These studies were performed using both WT and transgenic mice.  The 
transgenic mice (CypD-null) features a homozygous deletion of the CypD 
encoding gene Ppif (peptidylprolyl isomerase F).     CypD-null mice were 
generated on a chimeric strain using adult female C57BL/6 crossed to a SV129 
strain (B6129) (Baines et al. 2005).  The WT mice utilized were also B6129 
purchased from Taconic. 
Materials and Methods 
Mouse Model of Traumatic Spinal Cord Injury. All experimental procedures were 
conducted in accordance with the guidelines of the Institutional Animal Care and 
Use Committee (IACUC) of the University of Kentucky.  The spinal contusions 
administered in these studies were conducted using the commercially available 
Infinite Horizon (IH) spinal cord injury device (Precision Systems & 
Instrumentation (PSI), Lexington, KY).  The IH impactor allows for user defined 
parameters to achieve the desired severity of injury.  There are three parameters 
measured by the IH impactor and defined as follows: 1. Force as the actual force 
delivered by the impactor compared to the calibrated force, 2. Velocity as the 
speed of the impactor tip as it delivers the contusion, and 3. Displacement as the 
elasticity of the spinal cord required until the calibrated force is achieved.  The 
force of the contusion, measured in kilodyns, was calibrated according to each 
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severity.  For mild injury, a calibrated force of 30kdyn was used.  For the 
moderate injuries, a calibrated force of 50kdyn was used.  Finally, for the severe 
contusions, a calibrated force of 70kdyn was used. These settings were derived 
from a previous study characterizing injury gradients in the mouse model (Basso 
et al. 2006).  Mice were anesthetized by an intraperintoneal injection ketamine 
(80mg/kg) and xylamine(10mg/kg).  Laminectomies were made to expose the 
T10 vertebral segment.  Two clamps were applied approximately at the caudal 
T11 segment and the rostral T9 segment.  The spinal cord was then lowered and 
straightened until parallel with the platform.  Sham animals received a 
laminectomy only.  Following surgery, all animals were placed on a heating pad 
set at 37°C until consciousness and mobility (upper limbs) was regained.  
Postoperative care included the manual expression of bladders twice daily until 
recovery of bladder function, injection with 10 ml sterile saline administered 
subcutaneously (s.c.) immediately after surgery, 33.3 mg/kg cefazolin, 
administered by intramuscular injection, twice a day for 1 week then once a day 
for the remaining 3 weeks. 
Hind Limb Motor Function Assessment.  Motor function following spinal cord 
injury was measured by two raters blinded to the experimental conditions.  Hind 
limb motor function was measured using the Basso Mouse Scale (BMS), a 9 
point categorical scale that rates seven observable motor functions and motor 
deficits.  The seven categories in the BMS included ankle extension, of hind limb 
joint movements, trunk stability, stepping coordination, paw placement, and tail 
position (Basso et al. 2006).  A single score was recorded for the left and right 
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hind limb which was then averaged to give a total score.  An 11 point subscore 
was obtained to assess subtle variations within each category.  Each BMS test 
was assessed by two examiners. One examiner is the main observer while the 
other examiner observes and records the scores during the exam.  This is to 
ensure that one person is observing the test for the entire duration.  Each trial is 
4 minutes.   
Histological Assessment of Spinal Cord Tissue Sparing.  Mice were given an 
overdose injection of pentobarbital followed by a cardiac perfusion of cold 1x 
PBS and 4% PFA.  Spinal cords blocks 2 cm in length, centered at the lesion 
epicenter, were dissected, post-fixed in the same 4% PFA solution for 24 h at 4°C 
followed by submersion in 25% sucrose solution at 4°C to ensure cryoprotection. 
Spinal cords were cryosectioned at a thickness of 20microns and mounted onto 
gelatin-coated slides and stored at -20C.  For histological staining, the gelatin-
coated slides were allowed to thaw to room temperature.  Each slide was then 
cleared and hydrated in Citrisolv followed by ethanol concentration gradient.  
Slides were then submerged in an eriochrome cyanine staining solution (10% 
FeCl3 and .2% ECRC).  The slides were submerged in a differentiation solution 
for 10 seconds followed by a wash in H20 then allowed to dry overnight.   
Spinal cord tissue was assessed using a modified eriochrome cyanine 
staining protocol for myelin that stains for both white matter and neuronal cell 
bodies.  Tissue sparing was assessed from area measurements of white matter, 
gray matter, and total lesion volume.  Total tissue sparing is reported as a 
percentage calculated as follows: 1-(Lesion area/ Total cross sectional area) x 
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100.  Spared white matter was calculated as follows: Total cross sectional area - 
Lesion area - Gray matter area.     
Spinal Cord Processing for Western Blot Analysis of Calpain Activity.  Spinal 
cords segments were thawed and cut into 10mm long sections containing the 
injured site and weighed. The spinal sections were homogenized in 50mM 1X 
TBS(Tris, NaCl, H20; pH 7.5).  Spinal cord homogenates were spun at 32,000 
rpm for 30 minutes to separate the supernatant and pellet.  The pellets were 
reconstituted in protease inhibitor with 2% SDS( 50mM TBS pH 7.5, .5M EDTA 
pH 8.9, 100mM AEBSF, 10mM Leupeptin, 1.5mM Pepstatin) and spun at 32,000 
rpm for 30 minutes and the supernatant recovered and frozen at -20OC.  Brain 
cortex samples thawed and weighed out.  Both spinal cord and brain tissue were 
homogenized in a 1X Tris-Saline with protease inhibitors (50mM TBS pH 7.5, 
.5M EDTA pH 8.9, 100mM AEBSF, 10mM Leupeptin, 1.5mM Pepstatin) and 
spun at 33,000 RPM for 20 minutes. Supernatant was recovered and frozen at -
20OC.  Samples were loaded at 20ug into a 6.5% gel followed by a transfer onto 
a nitrocellulose membrane. The membranes were washed in 1X TBS then 
blocked in 5% milk/1X TBS solution for 1 hour.  For detection of spectrin in spinal 
cord and brain cortex samples, membranes were incubated overnight with MAS 
spectrin AB at 1:10,000 dilution in a 5 ml, 5% milk/1X TTBS solution (10XTBS, 
Tween 20, D-H2O). Membranes were washed the following day in TTBS then 
incubated with fluorescently conjugated secondary antibody solution at 1:5000 in 
for 1 hour in a 5 ml, 5% milk/1X TTBS solution (10XTBS, Tween 20, D-H2O).  
Membranes are then washed in 1X TTBS and visualized on Odyssey Imager.  
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IH impactor parameters: Data from the IH impactor were analyzed by two-tailed 
unpaired Student’s t-Test. Significance was set at P<0.05, 95% C.I. Data 
reported represents mean +/- STDEV.  .   
 Statistical Analysis of Each Experimental Aim 
Hind limb motor assessment: Data from BMS test were analyzed by repeated 
measures two-way ANOVA followed by Bonferroni post hoc test.  Significance 
was set at P<0.05. The two independent variables in this study are the mouse 
type (WT and CypD-null) and time post injury.  F scores are reported as F score 
Interaction (F score Mouse, F score Time).  Data reported represents mean +/- 
STDEV.   
Histological assessment of tissue sparing: Data recorded from histological 
assessment of spinal cord tissue was analyzed by ANOVA followed by Tukey’s 
multiple comparison post hoc test.  Significance was set at P<0.05, 95% C.I.  
Data reported represents mean +/- STDEV.   
Calpain activity:  Data from WB analyses of calpain activity were analyzed by 
Two-way ANOVA followed by Bonferroni post hoc test. Significance was set at 
P<0.05, 95% C.I. Data reported represents mean +/- STDEV. All Data were 
analyzed using GraphPad Prism.  
Inclusion and Exclusion Criteria:  For the current study, animals subjected to 
spinal cord contusion by the IH impactor must register a delivered calibrated 
force +/- 5kdyns to ensure an appropriate contusion severity.  Additionally, 
animals must display post operative paralysis upon recovery from anesthesia, a 
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time of approximately 1 hour.  Animals must only display ankle extension or 
ankle extension and plantar or dorsal placement of the paw without weight 
support. This is a BMS rating of 3, though the data is not reported here. This 
criterion is based on our pilot study which showed CypD-null mice subjected to 
spinal contusion did not display an acute recovery and exhibited hind limb 
paralysis as observed in WT mice. After 24h of recovery, no mouse model may 
be excluded regardless of recovery rate. The only exception is death or illness 
that prevents any further testing as determined by veterinarian staff.   
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Infinite Horizon Impact Parameters.  
Results 
 Table 1 displays the recorded Infinite Horizon (IH) impact parameters for all 
spinal cord contusion studies.  Table 1A shows that for mild spinal contusions, 
there was no significant difference in force, displacement, or velocity of the 
impact tip in CypD-null mice compared to WT mice.  Table 1B shows that for 
moderate spinal contusions, there was no significant difference in force, 
displacement, or velocity of the impact tip in CypD-null mice compared to WT 
mice. Table 1C shows that for severe spinal contusions, there was no significant 
difference in force, displacement, or velocity.  
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Mouse Force (kDyn) Displacement(microns) Velocity(ms) 
CypD-/- 32 +/- 2 264 +/- 25 122 +/- 1 
WT 32 +/- 2 238 +/- 30 122 +/- 2 
Mild Spinal Contusion 
Mouse Force (kDyn) Displacement(microns) Velocity(ms) 
CypD-/- 53 +/- 2 499 +/- 84 123 +/- 2 
WT 54 +/- 2 493 +/- 143 123 +/- 3  
Moderate Spinal Contusion 
Mouse Force (kDyn) Displacement(microns) Velocity(ms) 
CypD-/- 73 +/- 2 849 +/- 102 120 +/- 3 
WT 73 +/- 1 811 +/- 72 124 +/- 4 
Severe Spinal Contusion 
Table 1 Infinite Horizon (IH) parameters for mild, moderate and severe spinal 
cord contusion. A.  For mild SCI, there were no significant differences in IH 
parameters. B. For moderate SCI, there were no significant differences in IH 
parameters. C. For severe SCI, there was a significant no significant difference in 
IH parameters. Values=Mean +/- STDEV. Two tailed paired student’s t-test. 
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Hind Limb Motor Function Assessment  
 The Basso Mouse Scale (BMS) analysis, a 9 point categorical scale, was 
used to assess CypD-null and WT mice for open field motor function following 
moderate, mild and severe SCI over a period of 4 weeks.  Immediately following 
spinal impact, both animal models displayed complete bilateral hind limb 
paralysis as evident by ankle extension only or ankle extension plus plantar 
placement without weight support for all gradients of contusion (data not shown).  
This immediate observation was to assess the consistency of the contusion 
across all models (Springer et al. 1997).  
Figure 5.1A and B show that following moderate SCI, there was no 
significant difference in BMS scores and subscores for functional motor recovery 
between the two models after 4 weeks. However, both models did display 
gradual improvement at 3 days post spinal contusion in ankle extension and 
plantar placement. By the second week, both models showed further 
improvements in plantar placement with weight support and stepping 
coordination in addition to paw position and trunk stability.  By week 3, both WT 
and CypD-null regained most coordination and showed only mild trunk instability 
as indicated by a side to side tail sway.  The improvements observed at week 3 
reached a plateau, as no greater improvements were observed in week 4. 
Fig 5.2A and B show that following mild spinal contusion, there was no 
was no significant difference in BMS scores and subscores for functional motor 
recovery between the two models after 4 weeks.  By 3 days post injury, both WT 
and CypD-null displayed consistent plantar stepping, regained most coordination 
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and displayed only mild trunk instability.  By 1 week post injury motor recovery 
skills had reached a plateau as no more improvements were observed for the 
remaining 3 weeks.   
Figure 5.3A and B show that following severe spinal contusion, there were 
significant differences in BMS scores and subscores for functional motor 
recovery between the two models at select time points after 4 weeks.  Figure 
5.3A shows a significant difference in BMS scores at weeks 1,2,3, and 4 
[F=18.27(1027,44.65); p<.001].  By 1 week post injury, WT mice regained some 
ability for weight supported stepping where as CypD-null showed only extensive 
ankle extension with some plantar placement.  WT mice continued to show motor 
improvement with recovery of most coordination, consistent stepping, and an 
upgrade in trunk instability from severe to mild.  CypD-null mice failed to show 
the same recovery over 4 weeks.  CypD-null mice showed significantly lower 
recovery at each time point from 1 week until 4 weeks of BMS testing.  By 4 
weeks testing, CypD-null mice displayed only occasional to frequent weight 
supported stepping with recovery of some coordination.  Trunk instability in 
CypD-null  mice never improved above severe.  The poor motor recovery of 
CypD-null mice is further illustrated by the BMS subscores in Figure 5.3B.  CypD-
null never achieved any subscore above 0 at any time point.  WT mice also 
achieved subscores of 0 from day three to the second week of testing.  However, 
at weeks 3 and 4 WT mice scored significantly higher BMS subscores as they 
regained consistent plantar stepping and coordination [F=19.11(882.7,19.11); 
p<.001].   
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BMS Scores After Mild SCI
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BMS Subscores After Mild SCI
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Figure 5.1 Basso Mouse Scale(BMS) scores and subscores for WT and CypD-
null  sham and injured mice at 3d, 1wk, 2wk, 3wk, and 4wk post moderate injury.  
A. No significant differences in BMS scores between WT injured and CypD-null 
injured mice at any time point following moderate SCI.  B. No significant 
differences in BMS subscores between WT injured and CypD-null injured mice at 
any time point following moderate SCI.  Values=Mean +/- SD. Two-way ANOVA 
and Bonferroni post hoc test. N=6 per injury group and 3 per sham group.  
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BMS Scores After Moderate SCI
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BMS Subscores After Moderate SCI
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Figure 5.2 Basso Mouse Scale(BMS) scores for WT and CypD-null  sham and 
injured mice at 3d, 1wk, 2wk, 3wk, and 4wk post mild injury.  A and B.  No 
significant differences in scores or subscores for WT injured and CypD-null 
injured mice at any time point following mild SCI.  Values=Mean +/- SD. Two-way 
ANOVA and Bonferroni post hoc test. N=6 per injury group and 3 per sham 
group.  
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BMS Scores After Severe SCI
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Figure 5.3 Basso Mouse Scale(BMS) scores for WT and CypD-null sham and 
injured mice at 3d, 1wk, 2wk, 3wk, and 4wk post severe injury.  A. There was a 
significant difference in BMS scores between WT injured and CypD-null injured 
mice at select time points following severe SCI  [***p<.001, F=18.27(1027, 44.65 
) at 1wk, 2wk, 3wk, and 4wk]. B.  There was a significant difference in BMS 
subscores between WT injured and CypD-null2 injured mice at select time points 
[***p<.001, F=19.11(882.7, 19.11) at 3wk and 4wk]. Values=Mean +/- SD. Two-
way ANOVA and Bonferroni post hoc test. N=6 per injury group and 3 per sham 
group. 
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Histological Assessment of Spinal Cord Tissue Sparing 
Following the 4th week of BMS analysis, all mice were euthanized and volumetric 
measurements were conducted by histological assessment for total spared 
tissue, white matter, and grey matter following moderate and severe spinal cord 
injury.  Histological staining showed that following moderate injury, both CypD-
null and WT injured mice had the greatest spinal tissue loss at the impact site, or 
the epicenter, with damage extending primarily in the caudal direction with some 
injury extending in the rostral direction (Figure 6.1). The epicenter of injury in 
both groups, approximated at the thoracic level of T-10, was characterized by a 
dense fibrous matrix encompassing the cross sectional area of the tissue (Figure 
6.1). This lesion was not present in WT or CypD-null sham mice (Figure 6.1).   
Figure 6.2 shows the histological assessment for spared tissue following 
moderate SCI.   There was no significant difference in the volume of spared 
tissue between CypD-null  injured and WT injured mice (Figure 6.2A).  Both 
injured mice showed a significant reduction in spared tissue compared to both 
sham mice [p<.01, F(24.61) for all injury vs shams]. A rostral to caudal expansion 
of the percentage of spared tissue is represented in figure 6.2B.  There was no 
significant difference in the percentage of spared tissue at any spinal segment. 
Figure 6.3 shows no significant reduction in lesion volume in CypD-null injured 
mice compared to WT injured mice.  Measurements of spared white matter 
showed no significant improvements in CypD-null mice compared to WT mice as 
measured by ANOVA (6.4A).  A rostral to caudal expansion of spared white 
matter area is represented in figure 6.4B.  There was a statistical significant 
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difference in white matter area at the most rostral section for CypD-null  mice 
compared to WT  mice [p<.05, F=1.763(4.450,42.01)].  However, at this rostral 
section, there is no measurable tissue damage and the increase white matter is 
likely from compression of the rostral most segments during tissue mounting.  
Measurements of spared gray matter showed no significant improvements in 
CypD-null injured mice compared to WT mice (Figure 6.5A).  A rostral to caudal 
expansion of gray matter area is represented in Figure 6.5B.  CypD-null mice 
showed a statistically significant increase in grey matter area compared to WT 
injured mice[p<.001; F=6.613(12.01,104.7)].  Again, at this rostral section there 
was no measurable tissue damage.  
Figure 7.1 shows histological assessment for spared tissue following severe SCI.  
Figure 7.2A shows a significant reduction in the volume of spared tissue in CypD-
null injured mice compared to WT inured mice [ p<.01; F(86.80);  for CypD-null 
injury vs sham; p<.001 all injury vs all sham].  A rostral to caudal expansion of 
the percentage of spared tissue is represented in Figure 7.2B.  CypD-null injured 
mice showed a significant reduction in the percentage of spared tissue at select 
sections both caudal and rostral from the epicenter compared to WT injured mice 
[p<.01; F10.73(67.20, 182.2) at 1mm and -1mm; p<.001 at 2mm and -2mm].  
Figure 7.3 shows no significant difference in lesion volume in CypD-null injured 
mice compared to WT injured mice. Measurements of spared white matter 
showed that  CypD-null injured mice had a significant reduction compared to WT 
injured mice (Figure 7.4A) [p<.01; F=(59.25)].  A rostral to caudal expansion of 
the spared white matter area is represented in Figure 7.4B. CypD-null injured 
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mice showed significant reductions in spared white matter at select sections both 
rostral and caudal from the epicenter compared to WT injured mice [p<.01 at 
1mm, 4mm, 6mm; p<.001 at 2mm, 3mm; F=4.744(108, 36.63)].  Figure 7.5A 
shows that gray matter was also significantly reduced in CypD-null injured mice 
compared to WT mice [p<.001; F=(71.87)]. A rostral to caudal expansion of 
spared grey matter is represented in Figure 7.5B.  CypD-null mice showed a 
significant reduction in gray matter sparing at select sections both rostral and 
caudal to the epicenter [p<.01 at -3mm, 5mm; p<.001 at 2mm, 3mm, 4mm, 6mm; 
F=7.73(159.5, 89.14)].  
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Figure 6.1 Histological assessment showing rostral(-mm) to caudal(mm) 
expansion of moderate injured spinal cord sections or laminectomy only (sham 
models) in CypD-null and WT mice. The epicenter is the point of impact as 
evident by large lesion volume.  Lesions in the injured animal extend into the 
caudal section below the epicenter.  
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Figure 6.2 Total tissue sparing for WT and CypD-null mice 4weeks post 
moderate spinal contusion.  A. The volume of total tissue sparing. No significant 
difference in the volume of total tissue sparing was recorded in CypD-null and 
WT injured mice. Values=Mean +/- STDEV.  ANOVA and Tukey’s multiple 
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comparison post hoc test. N=6 for injured group and N=3 for sham group.  B. 
The percentage of total tissue sparing represented in a caudal to rostral 
expansion. No significant difference in the percentage of total tissue sparing was 
recorded at any section at both caudal and rostral direction from the epicenter in 
CypD-null and WT injured mice. Values=Mean +/- STDEV.  Two-way ANOVA and 
Bonferroni post hoc test. N=6 for injured group and N=3 for sham group.   
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Figure 6.3.  Lesion volume for WT and CypD-null  mice 4 weeks post moderate 
spinal contusion. No significant difference was recorded in lesion volume 
between WT and CypD-null injured mice. Values=Mean +/- STDEV.  ANOVA and 
Tukey’s multiple comparison post hoc test.  N=6 for injured group and N=3 for 
sham group.   
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Figure 6.4 White matter sparing for WT and CypD-null  mice 4 weeks post 
moderate spinal contusion.  A. Quantification of white matter sparing. No 
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significant difference was recorded in the white matter sparing in CypD-null 
injured mice compared to WT injured mice. Values=Mean +/- STDEV.  ANOVA 
and Tukey’s multiple comparison post hoc test. N=6 for injured group and N=3 
for sham group.  B. Rostral to caudal expansion of white matter sparing.  White 
matter sparing was significantly increased in CypD-null injured mice compared to 
WT injured mice at rostral section -4mm from the epicenter. Values=Mean +/- 
STDEV.   *p<.05; Two-way ANOVA and Bonferroni post hoc test.  N=6 for injured 
group and N=3 for sham group.   
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Figure 6.5 Grey matter sparing for WT and CypD-null  mice 4 weeks post 
moderate spinal contusion. A. Quantification of grey matter sparing. No 
significant difference in total tissue sparing in CypD-null injured mice compared 
to WT injured mice. Values=Mean +/- STDEV.  ANOVA and Tukey’s multiple 
comparison post hoc test. N=6 for injured group and N=3 for sham group.  B.  
Rostral to caudal expansion of grey matter sparing. Grey matter sparing was 
significantly increased in CypD-null injured mice compared to WT injured mice at 
the caudal section -4mm from the epicenter.  Values=Mean +/- STDEV.   ***p<.01;  
Two-way ANOVA and Bonferroni post hoc test. N=6 for injured group and N=3 
for sham group.   
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Figure 7.1 Histological assessment showing rostral(-mm) to caudal(mm) 
expansion of severe injured spinal cord sections or laminectomy only (sham 
models) in CypD-null and WT mice. The epicenter is the point of impact as 
evident by large lesion volume.  Lesions in the injured animal extend into the 
caudal section below the epicenter. 
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Figure 7.2 Total tissue sparing for WT and CypD-null mice 4 weeks post severe 
spinal contusion. A. Quantification of total tissue sparing. Total tissue sparing 
was significantly decreased in both CypD-null and WT injured mice compared to 
both sham models.  Total tissue sparing was a significantly decreased in CypD-
null injured mice compared to WT injured mice. Values=Mean +/- STDEV. 
***p<.01; ANOVA and Tukey’s multiple comparison post hoc test. N=6 for injured 
 61 
group and N=3 for sham group.  B. Rostral to caudal expansion of white matter 
sparing expansion. There was a significant decrease in CypD-null injured mice 
compared to WT injured mice at the rostral section of -1mm and -2mm and at the 
caudal sections 1mm, 2mm, and 3mm from the epicenter. Values=Mean +/- 
STDEV.  *p<.05, **p<.01, ***p<.001; Two-way ANOVA and Bonferroni post hoc 
test.  N=6 for injured group and N=3 for sham group.   
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Figure 7.3  Lesion volume for WT and CypD-null mice 4 weeks post severe 
spinal contusion. No significant difference was recorded in lesion volume 
between WT and CypD-null injured mice. Values=Mean +/- SD.   N=6 for injured 
group and N=3 for sham group.   
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Figure 7.4  White matter sparing for WT and CypD-null mice 4 weeks post 
severe spinal contusion. A. Quantification of white matter sparing volume. White 
matter was significantly decreased in CypD-null injured mice compared to WT 
injured mice. Values=Mean +/- STDEV.  **p<.01, ***p<.001. Data by ANOVA and 
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Tukey’s multiple comparison post hoc test. N=6 for injured group and N=3 for 
sham group.  B. Rostral to caudal expansion of white matter sparing.  White 
matter sparing was significantly reduced in CypD-null injured mice compared to 
WT injured mice (**p<.01 at the caudal section at 1mm, 4mm; ***p<.001 at 2mm, 
3mm, 6mm). Data by Two-way ANOVA and Bonferroni post hoc test.  N=6 for 
injured group and N=3 for sham group.  Values=Mean +/- STDEV.  
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Figure 7.5 Grey matter sparing for WT and CypD-null mice 4 weeks post severe 
spinal contusion. A. Quantification of grey matter sparing volume. Grey matter 
was significantly decreased in CypD-null injured mice compared to WT injured 
mice.  Grey matter was significantly decreased in CypD-null and WT injured mice 
compared to CypD-null and WT sham mice (***p<.001 for all shams vs all injured 
and CypD-null injured vs WT injured). Data by ANOVA and Tukey’s multiple 
comparison post hoc test. N=6 for injured group and N=3 for sham group. 
Values=Mean +/- STDEV.  B. Rostral to caudal expansion of grey matter sparing.  
Grey matter sparing was significantly reduced in CypD-null injured mice 
compared to WT injured mice(**p<.01 at  -3mm, 5mm; ***p<.001 at -2mm, 2mm, 
4mm, 6mm).  Data by 2way ANOVA and Bonferroni post hoc test.  N=6 for 
injured group and N=3 for sham group.  Values=Mean +/- STDEV.   
 
 
 
 65 
Western Blot Analyses of Calpain activity following  Moderate SCI 
Calpain activity, as measured by calpain mediated spectrin metabolism 
was assessed 24 hours following moderate spinal cord contusion.  Western blot 
analysis of SBP produces three distinct bands.  Total intact spectrin, defined as 
spectrin levels before enzyme catalysis, produces a specific band at 280kDa. 
Total spectrin breakdown product (tSBP), defined as combined calpain and 
caspase mediated metabolism of spectrin, produces a band at 150kDa.  Calpain 
mediated spectrin (cSBP), defined at metabolism of spectrin exclusively by 
calpain, and produces a specific band at 145 kDa. 
Figure 8.1A shows western blot analysis of total spectrin levels 24 hours 
following moderate SCI.  Figure 8.1B shows that CypD-null injured mice had no 
significant decrease in total spectrin levels mice compared to injured WT mice or 
compared to both mouse sham models.  Figure 8.2A shows western blot analysis 
of tSBP 24 hours following moderate SCI.  There was no significant decrease in 
calpain mediated SBP in injured CypD-null mice compared to injured WT mice. 
Figure 8.2 B shows no significant difference in cSBP in CypD-null injured mice 
compared to WT injured mice.  There was a significant difference in calpain 
specific SBP in injured injured WT mice compared to both mouse sham models 
[p<.001; F(9.595)].  
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Figure 8 Western blot and quantative analysis of total spectrin and SBP in CypD-
null and WT sham and injured mice 24h post SCI. A. Quantitative analysis of 
total spectrin levels (280kDa) shows no significant difference in CypD-null and 
WT sham and injured mice. B. Quantitative analysis of total SBP (150kDa) 
shows no significant difference in CypD-null and WT sham and injured mice. C. 
Quantitative analysis of calpain-mediated SBP (145kDa) shows a significant 
difference in WT injury compared to CypD-null and WT sham (**p > .01). Data 
measured by ANOVA with Tukeys Multiple Comparison post hoc test. N=4 per 
group. Values=Mean +/- STDEV.  
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The principal finding in our study was that mice with a homozygous knockout of 
CypD, the regulatory component in mPTP formation, showed no significant 
improvement in motor function, tissue sparing, or calpain activity following spinal 
contusion. The purpose of this study was to assess the role of CypD in 
neuroprotection following spinal cord and brain injury.  Recent reports have 
shown confounding results in the efficacy of CypD as a therapeutic target in SCI 
(Rabchevsky et al. 2001; Ravikumar et al. 2007).  Following brain injury, 
treatment with the CypD inhibitor cyclosporin A improved behavioral function and 
cortical tissue sparing (Sullivan et al. 2000; Sullivan et al. 2004).  However, the 
same dose regiment of cyclosporine A failed to provide protection following SCI 
(Rabchevsky et al. 2001).  The only protection following SCI observed from 
cyclosporin A was elicited at toxic doses.  In contrast, a recent study using 
NIM811, a non immunosuppressive cyclosporin derivative, recorded decreased 
lesion size, preserved mitochondrial bioenergetics, and improved tissue sparing 
and motor function following spinal cord injury (McEwen et al. 2007; Ravikumar 
et al. 2007).  Thus, the role of CypD in neuroprotection following spinal cord 
injury remains uncertain.   
Discussion 
In the current study, we directly addressed the role of role of CypD in SCI 
by utilizing mice deficient for CypDl.  The first assessment for improved outcome 
following injury was hind limb motor function using the Basso Mouse Scale 
(BMS) for 4 weeks following different severities of SCI.  The mild contusion 
produced very minimal motor deficits in both CypD-null and WT mice.  This rapid 
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recovery of motor function in both models would make any protective effects of 
CypD-null difficult to assess.  Following a moderate contusion, both WT and 
CypD-null mice displayed complete hind limb paralysis immediately following the 
injury.  However, both WT and CypD-null mice showed similar recovery from the 
moderate contusion. These results may question the sensitivity and selectivity of 
the BMS as a means for measuring motor function following spinal contusion.  
Some motor deficits, such as those resulting from gray matter damage, may be 
masked by white matter damage and go undetected by BMS measurement.  
However, this seems unlikely since spinal contusions were administered at the 
lower thoracic level of T10.  Motor neurons and interneurons of the grey matter at 
this level primarily innervate axial muscles, having minor contributions to hind 
limb motor function.  Thus, lesions around the T-10 area produce motor deficits 
that are mostly exclusive to white matter damage (Magnuson et al. 1999).  It is 
possible that a moderate contusion does not produce a strong enough motor 
deficit to truly assess subtle changes.  Within the first week following the 
moderate spinal contusion, WT mice demonstrated an approximate 30% 
recovery in function.  WT mice were able to regain full weight support, most of 
their coordination with only minor irregular paw placement. Such extensive 
recoveries may make assessment of discrete motor improvements difficult.   
To address this concern, we administered a severe spinal contusion.  
Surprisingly, CypD-null mice failed to achieve the same level of motor recovery 
as WT mice.  Though, both mice did display complete hind limb paralysis 
following contusion, only WT mice showed gradual recovery of motor function 
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over the 4 weeks. CypD-null mice never achieved the same level of motor 
recovery as WT from the first week until the final fourth week.  These data 
suggest that a basic physiological level of functional CypD is necessary for cell 
survival.  These data clearly show that CypD knockout in mice offers no 
improved motor recovery following spinal cord injury regardless of the severity.   
Impairments in locomotor function are indicative of axonal damage and to 
an extent, gray matter damage.  Based on our results from the BMS assessment, 
it is not surprising that CypD-null mice showed no further improvement in any of 
the tissue measurements following moderate injury.  Both WT and CypD-null 
mice displayed epicenter lesions consistent with previous measurements of 
gradient contusions in various mouse strains (Kuhn et al. 1998; Jakeman et al. 
2000; Ghasemlou et al. 2005).  However, the extension of the lesion was mostly 
exclusive to sections caudal to the epicenter.  Again, these results are 
contradictory to previous findings in rodent models of spinal cord injury (McEwen 
et al. 2007; Ravikumar et al. 2007).  
A possible explanation for these discrepancies, at least in spared tissue 
assessment, may stem from species specific inflammatory responses following 
SCI that mediate degeneration and healing (Zhang et al. 1996; Guth et al. 1999; 
bZhang et al. 2003; Sroga et al. 2003).  The fibrous matrix of connective tissue, 
as shown at the epicenter, is in sharp contrast to the cyst-like fluid cavitation of 
the epicenter observed in rats (Sroga et al. 2003).  Mice follow a unique 
secondary response compared to rats in which delayed inflammatory cell 
infiltration may contribute more towards wound healing instead of secondary 
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neurodegenertion (Guth et al. 1999; Sroga et al. 2003).  Any protective effects of 
CypD ablation may be masked by a more universal healing mechanism in the 
mouse model.  Though, rats do display cellular markers of wound repair, these 
events are largely overwhelmed by destructive inflammatory reaction (Sroga et 
al. 2003).  Thus, the effects that CypD ablation or other therapeutic strategies 
may have on tissue sparing may be more evident in rats at earlier stages of 
secondary response.   
If this were the case, the unique healing response in mice would be 
expected for all severities of spinal contusion.  When we administered a severe 
contusion, WT mice did display a similar epicenter lesion as measured during 
moderate contusion.  In CypD-null mice, however, the entire epicenter was 
encompassed by a lesion that persisted in sections above and below the site of 
injury.  In moderate contusions, lesion reduction was seen in the immediate 
sections below the site of injury.  Furthermore, the decreased tissue sparing in 
CypD-null mice compared to WT mice suggest that CypD may be necessary for 
cellular support in the spinal cord following a severe injury.         
Cellular alterations following spinal cord injury may offer a more discrete 
assessment of the mechanisms involved in secondary damage, particularly in the 
acute intermediate stages of injury.  The secondary pathophysiological events 
that follow spinal injury activate and mobilize deleterious catalytic proteins 
(Anderson et al. 1993; Lynch et al. 1994; Moriya et al. 1994).  A selection of 
these catalytic proteins may be activated following mPTP formation. Of particular 
interest is the sustained activation of Ca2+ dependent calpains.  Extensive 
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studies of calpain have demonstrated their involvement in cell structural damage 
and mediation of apoptotic and necrotic death (Wingrave et al. 2004; Momeni et 
al. 2006; Deng et al. 2007; Momeni et al. 2007).  Two recent studies showed that 
onset of mPTP activated calpain, an effect that was blocked by administering 
cyclosporine A (Ding et al. 2002; Ferrand-Drake et al. 2003).  Increased 
activation of the calpain isoform Calpain 1 has also been documented within 1h 
and as far out as 24h following spinal injury in rats (Springer et al. 1997).  These 
reports demonstrate that calpain activation can result from mPTP opening.   
Thus, we hypothesized that CypD ablation would mediate protective 
effects by decreasing calpain activity, as measured by spectrin metabolism 
(cSBP).  However, our data showed that cSBP was not reduced in CypD-null 
mice compared to WT mice.  Though, cSBP was measured at 24h post injury, 
other reports have shown that calpain is still elevated at this time (Springer et al. 
1997).  Additional time points closer to the time of injury may produce stronger 
effects, calpain activity at 24h is still a viable time point.  It is unlikely that calpain 
has a minor role in secondary damage, as cSBP is elevated in both WT and 
CypD-null injured mice compared to sham models.  Thus, calpain activity may be 
a critical mediator of secondary damage in spinal cord injury.  However, the 
metabolism of spectrin may not be indicative of the extent of calpain-induced cell 
death.  Additional substrates of calpain may provide more sensitive 
measurements. 
The potential for CypD as an effective target in spinal cord inury remains 
uncertain. The results reported here and in previous studies have been 
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conflicting and difficult to interpret.  Several scenarios exist that may explain why 
protection from targeting CypD is still elusive. 
  Spinal mitochondria have an inherent vulnerability even under 
physiological conditions. This is evident by alterations in spinal mitochondrial 
intrinsic properties, such as a basic lowered calcium retention, reduced mPTP 
threshold, and a hampered Ca2+ transport and buffering system (Sullivan et al. 
2004; Sullivan et al. 2005; Morota et al. 2007).  Spinal neurons also show 
increased ROS and subsequent lipid peroxidation and DNA oxidation compared 
to cortical neurons (Sullivan et al. 2004).  Thus, spinal neurons are readily 
susceptible to insult making therapeutic protection difficult.  The intrinsic nature of 
spinal mitochondria becomes a greater factor when considering the complex 
pathology of spinal cord injury.  Though, cypD can induce both necrotic and 
apoptotic cell death, it is the collective actions of several degenerative pathways 
that may illicit the greatest damage (Schneider 2005; Forte et al. 2007)).   
Apoptosis is a major inducer of secondary pathology following spinal cord 
injury and is suggested to be the primary mediating cause of glial cell death 
(Beattie et al. 2000).   For example, oligodendrocytes, supportive glial cells that 
are fundamental to maintaining axonal integrity, readily undergo apoptosis 
following spinal cord injury.  Inhibition of FAS and p75, receptor targets for 
apoptotic stimuli, has shown to reduce cell death and improve axonal 
preservation in rodent models of spinal cord injury (Casha et al. 2001; Casha et 
al. 2005; Ackery et al. 2006).  Additional studies have shown that attenuation of 
other apoptotic stimuli, such as BAX, Bcl-2, and Fas ligand, resulted in improved 
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behavioral outcome and increased tissue sparing (Genovese et al. 2008; 
Genovese et al. 2008; Nocentini et al. 2008; Xu et al. 2009).  In contrast, a recent 
study showed that mitochondria isolated from CypD-null mice were not resistant 
to BAX and Bcl-2 release of cytochrome C, an apoptotic-inducing agent, from the 
mitochondrial inner membrane (Nakagawa et al. 2005).  Thus, increased 
mitochondrial permeability following spinal cord injury, as induced by apoptotic 
factors, may occur even in the absence of CypD.   
 Interestingly, several of the studies mentioned above were using 
pharmacological agents targeting multiple inflammatory processes involved in 
secondary spinal cord injury.  For example, a study from Genovese et al. showed 
that inhibition of the MAPK signaling cascade reduced key inflammatory 
mediators, such as neutrophil infiltration, pro inflammatory cytokine expression, 
and nuclear factor-kappaB activation, in addition to apoptotic markers (Genovese 
et al. 2008).  Another study from Xu et.al, used a combinational therapeutic 
approach of anti-inflammatory agents and showed similar reduction of apoptotic 
and inflammatory markers in compression models of spinal cord injury in rodents 
(Xu et al. 2009).  The effectiveness of these treatments suggests that 
inflammatory responses following spinal cord injury may be the prominent 
mediator in secondary damage.  Inflammatory responses can induce 
excitotoxicity and subsequent Ca2+ increase, which presents a favorable 
mechanisms for CypD mediated cell death (Beattie et al. 2000).  However, these 
studies, in addition to our findings, suggest that other inflammatory factors, 
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particularly apoptosis, may largely be responsible for secondary damage 
independent of CypD-mediated pathways.   
Though, multiple secondary cascades may overwhelm CypD 
mechanisms, the failed protective effects of targeting CypD may concern the 
anatomical makeup of the spinal cord.  CypD inhibition has shown to offer 
modest protection in animal models of brain injury (Sullivan et al. 2000; Mbye et 
al. 2008).  The underlying cortical regions in the brain consist of vast gray matter 
enriched in neuronal cell bodies.  In these cortical regions, CypD has been 
reported to be highly localized within neuronal mitochondria and to a greater 
extent the post synaptic mitochondria (Naga et al. 2007; Hazelton et al. 2009; 
Wang et al. 2009).  In contrast, the lower thoracic segments, as targeted in our 
model of spinal cord contusion, consist largely of axonal tracts with scarce 
neuronal cell bodies. Contusions in regions of the spinal cord where there is a 
greater area of gray matter, such as the cervical enlargement or the lumbar 
sections containing the central pattern generator, may show a more pronounced 
role for CypD following injury.  Other regional variations may stem from mPTP 
core components. Some exciting new studies in the identity and characteristics of 
the mPTP structure may provide clues to the discrepancies seen in SCI 
protection.  Basso et al., revealed that the inhibitory effects of cyclosporine A and 
NIM811 are dependent on the binding of phosphates to inhibitory regions on the 
mPTP(Basso et al. 2008).  In addition, Leung et al., revealed that an additional  
mPTP component, the phosphate carrier, can induce mPTP opening in a Ca2+ 
dependent manner (Leung et al. 2008).   
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The date presented here showed that CypD-null mice showed no 
improved outcome following spinal cord injury.  However, this is not to say that 
CypD has no role in the the pathology of spinal cord inury.  CypD may have a pro 
survival role in the spinal cord, at least under severe injury.  This concept has 
been suggested in a recent study from Wang et al.  Following hypoxic-ischemic 
(HI) brain injury, Wang showed that immature CypD-null mice were more 
susceptible to injury following hypoxic-ischemic (HI) brain injury.  Furthermore, 
induction of HI-induced brain injury in immature CypD-null mice was largely 
dependent on apoptotic mechanisms.  In adult CypD-null mice, the mechanism of 
HI brain injury shift to CypD-dependent pathways (Wang et al. 2009).  A potential 
dual role for CypD in the spinal cord is intriguing.  A possible model may show 
that spinal cord cells, particularly oligoglial cells, require some active CypD to 
maintain function.  Our models using a homozygous deletion of CypD may 
support this phenomenon.    
Basal levels of CypD activation, under strict regulation, may contribute to 
the preservation of mitochondrial integrity.  Uncoupling proteins have been 
shown to control the production of reactive oxygen species (ROS) in rodent 
models of brain injury (Davis et al. 2008; Davis et al. 2008).  Consider that mPTP 
formation and the subsequent increased permeability disrupt oxidative 
phosphorylation. If CypD-mediated mPTP formation can occur in a brief 
controlled burst, this may allow for momentary reduction of any ROS production.  
In addition, increased lipid peroxidation can produce clusters of misfolded 
proteins that form unregulated pores in the mitochondria membrane (He et al. 
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2002).  CypD, as a molecular chaperone, may properly fold these clustered 
proteins into a regulated channel (He et al. 2002).  Thus, the protection recorded 
using NIM811 still permits populations of mitochondria with functional CypD.  
Complete ablation of CypD presents an extreme environment that increases 
susceptibility as the injury becomes more severe.  A study using heterozygous 
knockout of CypD may support such a dual model of CypD.    
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These studies show the differing role of CypD in secondary neurological 
injury.  CypD-mediated mitochondrial permeability is a dynamic factor in cell 
death.  Therapeutic strategies that target CypD may offer protection following 
neurological injury.  However, these studies show that the contributions of CypD 
differ in selective models of injury.  In the pathological time course of spinal cord 
injury, CypD-mediated mechanisms may have only minor involvement.  In 
circumstances of severe spinal injury, CypD may actually be necessary for basic 
function of surviving neuronal and glial cells.  However, CypD-mediated death 
may have a larger role in other neurological injuries, specifically brain injury. 
Previous reports have shown that targeting CypD offers modest improvements in 
cortical damage.  Such functional diversity demonstrates that strategies aimed at 
single pathological mechanisms may not be sufficient.  In the event of spinal cord 
injury, consideration must be given to several factors.  Injury severity, regional 
and temporal factors may all reveal dual functions for CypD and CypD-mediated 
pathways of cell death.  Further investigation is warranted concerning the 
regional variation of CypD properties in the spinal cord and brain.  A better 
understanding of these regional discrepancies can lead to more effective 
therapeutic intervention in spinal cord injury.         
Conclusion 
 
.   
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Chapter Three 
The Role of Cyclophilin D in Traumatic Brain Injury 
 
Introduction
CypD has shown promise as a viable target for neurotrauma protection.  
Recent reports demonstrated the ability of cyclosporine A and its analog NIM811 
to attenuate cortical damage in rodent models of TBI (Sullivan et al. 2000; Mbye 
et al. 2008).  However, administrations of these inhibitors following spinal cord 
contusion rodent models produced confounding results.  Cyclosporine A has not 
offered the same extent of protection in SCI as seen in TBI, except in doses that 
are highly toxic (Rabchevsky et al. 2001; Morota et al. 2007).  NIM811 did offer 
moderate protection at the cellular level and in functional outcome following SCI 
at safe doses (McEwen et al. 2007; Ravikumar et al. 2007).  Furthermore, we 
recently showed that mice with a homozygous deletion of CypD encoding gene 
Ppif offered no increased protection from secondary damage following spinal 
cord contusion.  These discrepancies may be attributed to regional differences in 
brain and spinal cord pathologies that may subsequently alter drug efficiency.     
  
We sought to assess if this cortical protection would be consistent in our 
CypD-null mouse model.  We hypothesized that CypD-null mice will have 
improved pathological outcomes following cortical contusion.  To test this 
hypothesis, we employed a modified eriochrome cyanine staining for histological 
assessment of spared cortical tissue.  The results of our study show that ablation 
of CypD in mice is protective in tissue sparing following cortical contusion. 
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Animals.  All animals were housed in the Division of Laboratory Animal 
Resources sector of the University of Kentucky Medical Center, which is fully 
accredited by AAALAC. All experimental procedures abide by protocols approved 
by the University of Kentucky's Institutional Animal Care and Use Committee.  
These studies were performed using both WT and transgenic mice.  The 
transgenic mice (CypD-null) features a homozygous deletion of the CypD 
encoding gene Ppif (peptidylprolyl isomerase F). CypD-null mice were 
generated on a chimeric strain using adult female C57BL/6 crossed to a 
SV129F1 strain (B6129F1) (Baines et al. 2005).  The WT mice utilized were also 
B6129 purchased from Taconic. 
Materials and Methods 
Mouse Model of Traumatic Brain Injury. The cortical contusions administered in 
these studies were conducted using a commercially available impactor from 
Precision Systems & Instrumentation (PSI), Lexington, KY). According to PSI, the 
pneumatic driven IH cortical impactor uses a contact sensor that enables a more 
accurate determination of the cortical surface prior to contusion. There are three 
parameters measured by the IH cortical impactor and defined as follows: Force 
(kdyn) as the actual force delivered by the impactor compared to the calibrated 
force, 2. Velocity (ms) as the speed of the impactor tip as it delivers the 
contusion, and 3. Dwell Time (mm) as the elasticity of the cortex required until 
the calibrated force is achieved. Thee contact velocity is user controlled allowing 
different degrees of cortical deformation to achieve the desired injury severity. In 
these experiments, the contact velocity of the impactor was set at 3.5 ms to 
 81 
induce a moderate cortical contusion of .5mm. Mice were initially anesthetized in 
a Plexiglas chamber using 4.0% isoflurane and placed in a stereotaxic frame 
(David Kopf, Tujunga, CA, USA). Anesthesia was maintained throughout the 
entire surgery with 2.5% isoflurane delivered via a nose cone. The head was 
positioned on a horizontal plane with the nose bar set at zero. After a midline 
incision exposing the skull, an approximate 4.0 mm craniotomy was made lateral 
to the sagittal suture and centered between bregma and lambda. The craniotomy 
section was carefully removed to avoid excessive perturbance of the dura under 
the skull cap. The exposed cortex was injured using a pneumatically controlled 
impactor device with a 3.0 mm flat-tip diameter.  After injury, the craniotomy was 
closed by placement of a small disk of saline-moistened Surgical over the dura, 
followed by gluing a 6.0 mm disk made of dental cement over the site with super 
glue. The animals were placed on a heating pad set at 37°C until consciousness 
and mobility was regained. 
Histological Assessment of Cortical Tissue Sparing.  At 7 days post surgery, 
mice were given an overdose injection of pentobarbital followed by a cardiac 
perfusion of cold 1x PBS and 4% PFA.  Whole brain were dissected, post-fixed in 
the same 4% PFA solution for 24 h at 4°C followed by submersion in 25% sucrose 
solution at 4°C to ensure cryoprotection. Whole brains were cryosectioned at 25µm 
thickness and mounted onto gelatin-coated slides and stored at -20C.  For 
histological staining, the gelatin-coated slides were allowed to thaw to room 
temperature.  Each slide was then cleared and hydrated in Citrisolv followed by 
ethanol concentration gradient.  Slides were then submerged in a Cresyl stain 
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(1M acetic acid, sodium acetate, d H20, cresyl violet acetate).  The slides were 
submerged in d H20 followed by a reverse ethanol concentration gradient. 
Ipsilateral and contralateral cortical sections were assessed for percentage of 
spared tissue and lesion volume. 
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Histological Assessment of Spinal Cord Tissue Sparing 
Results 
At 4 week post cortical contusion or craniotomy, all mice were euthanized and 
volumetric measurements were conducted by histological assessment for total 
spared tissue and lesion volume.  Histological staining showed that following 
moderate contusion, both CypD-null and WT injured mice had the greatest spinal 
tissue loss at the impact site, or the epicenter, with damage extending 
Figure 9 shows spared tissue and lesion volume assessment in CypD-null and 
WT injured mice following moderate cortical contusion.  The percentage of 
spared tissue was calculated from measurements taken from the contralateral 
cortex of each animal (Figure 9A).  Analysis by two-tailed t-test showed that 
CypD-null mice had significantly greater tissue sparing compared to WT mice 
(Figure 9A)(p<.01).  Lesion volume was also measured in CypD-null and WT 
injured mice (Figure 9B).  Analysis by two-tailed t-test showed that CypD-null 
mice had a significant reduction in lesion volume compared to WT mice (p<.05).   
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Figure 9 Total tissue sparing for WT and CypD-null mice 1 week post moderate 
cortical contusion. A.  Percentage of total tissue sparing. CypD-null injured mice 
had significantly greater tissue sparing compared to WT injured mice. 
Values=Mean +/- SD.  **p<.01, t=3.387.  Two-tailed unpaired student’s t- test.  
N=10,11 for injured group.  B. Lesion volume.  CypD-null injured mice had a 
significant reduction in lesion volume compared to WT injured mice. 
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Values=Mean +/- SD.  *p<.05, t=2.662.  Two-tailed unpaired student’s t-test.  
N=10,11 for injured group.  
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The principal finding in our study was that mice with a homozygous 
knockout of cyclophilin D, the regulatory component in mPTP formation, showed 
significant improvement in cortical tissue sparing following moderate cortical 
contusion.  The purpose of this study was to assess the role of CypD in 
neuroprotection following traumatic brain injury.  Previous literature has shown 
CypD to be a viable target for neurological protection in rodent models of 
traumatic brain injury.  Cyclosporin A and NIM811, both potent inhibitors of 
CypD, improved motor function, increased cortical tissue sparing, and reduction 
in calpain-mediated cytoskeleton degradation following cortical contusion in rats 
(Mbye et al. 2008; Mbye et al. 2008; Wang et al. 2009). However, following spinal 
cord injury, these same CypD inhibitors produced contradictory results.   
Discussion  
Our preliminary findings support CypD as a viable target for attenuating 
secondary brain injury.  One week following administration of a moderate cortical 
contusion, CypD-null mice showed improved tissue sparing and a reduction in 
lesion volume compared to WT mice.  Interestingly, we recently showed that 
CypD-null mice had no improved outcome following spinal cord contusion.  
These findings suggest that both physiological and pathological differences in 
brain injury compared to spinal cord injury greatly affect the properties of CypD.    
Post traumatic mitochondrial dysfunction and permeability, for example, is 
readily induced due to Ca2+ overload following cortical injury.   Mitochondrial 
Ca2+ overload can also activate various mitochondrial free radicals that induce 
mPTP formation and mitochondrial dysfunction in a CypD dependent manner 
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(Ghafourifar et al. 1997; Richter et al. 1997; Mbye et al. 2008).   Furthermore, 
CypD was shown to be highly localized to synaptic mitochondria in the cortex 
(Naga et al. 2007).  These factors create a unique environment that is highly 
susceptible to CypD-regulated injury in cortical injury.  This is not to dismiss the 
importance of mitochondrial dysfunction and mPTP activity in spinal cord injury.  
However, the complex pathology of secondary spinal cord injury may induce 
formation of mPTP mitochondrial dysfunction independent of CypD regulation.  
Likewise, other secondary cascades, such as glial apoptotic death, may be the 
primary contributor to secondary spinal cord injury.    
The data presented in this study further supports CypD as a promising 
target for attenuating the secondary damage in brain injury.  Future studies 
should assess additional pathological outcomes following brain injury using 
CypD-null mice.  Measurements of behavioral outcomes, such as motor and 
cognitive function, may show additional protective effects of CypD ablation.  
Another intriguing study would be measurement of mitochondrial bioenergetics in 
CypD-null mice following brain injury. This should further confirm if the improved 
mitochondrial function, as demonstrated with CypD pharmacological inhibition in 
rats, is actually exclusive to CypD (Sullivan et al. 2000; Mbye et al. 2008).     
 
 
 
 
Copyright © Jordan Clark 2009 
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Chapter Four 
Summary and Conclusions 
Traumatic spinal cord and brain injury pathology consist of the primary 
injury and secondary injury.  The primary injury is the immediate damage induced 
by the initial mechanical contusion.  In the ensuing hours, days, and weeks a 
secondary cascade of deleterious events accelerates the pathological damage.  
Intervention and attenuation of primary damage is difficult due to rapid onset 
following the injury.  The events occurring in secondary damage, however, 
present a unique window of opportunity for therapeutic attention.  Thus, a 
thorough understanding of the pathological mechanisms in secondary damage 
will allow for more effective pharmacological and critical treatment following 
traumatic spinal cord and brain injury. 
Recently, cyclophilin D (CypD), the regulating component in mitochondrial 
permeability transitional pore formation (mPTP), has shown promise in 
attenuating secondary damage in brain injury.  However, the role of CypD in 
spinal cord injury is still uncertain.  In this series of studies, we utilized mice with 
a homozygous knockout of CypD in models of both spinal cord and brain injury.  
We were able to directly assess the role of CypD in spinal cord injury through 
measurements of motor function, tissue sparing, and calpain activation.  We 
hypothesized that CypD-null mice would have improved pathological outcomes 
following spinal cord and brain injury.  
Our first study utilized the Basso Mouse Scale (BMS) to measure hind 
limb motor function for 4 weeks following different severities of spinal contusions 
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CypD-null mice.  Following both mild and moderate spinal contusion, CypD-null 
showed no greater recovery of motor function than WT mice.  However, an 
unexpected outcome was produced when we administered a severe spinal 
contusion.  Motor impairment was exacerbated in CypD-null compared to WT 
mice.     
Our next study was a histological assessment of tissue sparing using 
eriochrome cyanine staining procedure that specifically stains white matter.  This 
procedure was employed immediately following the 4th week of BMS testing.  We 
measured total spared tissue, lesion volume, and white and grey matter.  The 
results of our histological measurements were consistent with our BMS results.  
In our moderate spinal contusion model, CypD-null mice showed no improved 
sparing of tissue.  Following severe spinal contusion, CypD-null mice showed a 
decrease in tissue sparing compared with WT mice.   
We concluded this series of studies by measuring calpain activity 24 hours 
following moderate spinal cord contusion.  Potentially, CypD-mediated death may 
be more prominent in the immediate stages of secondary injury.  We selected 
calpain based on previous literature that showed elevated calpain activity 
following spinal cord injury.  This increased calpain activity was attenuated when 
CypD was inhibited.  However, our Western Blot analysis of calpain, measured 
as calpain metabolism of spectrin, showed that CypD-null mice had no reduction 
in calpain activity compared to WT mice.    
Though pharmacological inhibition of CypD has shown to be protective 
following brain injury, we wanted to confirm these findings using our transgenic 
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model.  We presented some preliminary data showing that CypD-null mice had 
increased cortical tissue sparing and decreased lesion volume following a 
moderate cortical contusion.  Future studies should further assess additional 
improvements in brain injury pathology using CypD-null mice.  
In addition to our studies with CypD-null mice, we presented some 
preliminary data on the protective effects of NIM811 in SCI.  NIM811 was shown 
to have protective effects following SCI. However, those studies used rats for 
modeling SCI.  Thus, we wanted to examine the effects of NIM811 in mice.  Our 
results showed that NIM811 modestly improved motor function in WT mice.  
These improvements were observed at two weeks and three weeks following the 
spinal cord injury.    
In summary, our studies show that CypD is a viable target for attenuating 
damage following cortical contusion.  These protective effects were not observed 
in our models of SCI. We showed that CypD-null mice showed no improvements 
following moderate spinal cord injury.  However, the exacerbated deficits 
observed following severe injury suggest that some basic level of functional 
CypD is necessary for cell survival.   
This may seem contradictory as NIM811 did show moderate protection in 
rat models following SCI and in our study using mouse models.  However, drug 
inhibition of CypD does not affect all populations of mitochondria.  Thus, there is 
still functional CypD to maintain its physiological activity.  It is also feasible that 
NIM811 interacts with additional proteins other than CypD.  We did not examine 
the effects of NIM811 in CypD-null mice following SCI.  This would be an 
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intriguing study as it may reveal unique characteristics of NIM811 as well as 
mPTP regulation.    
These data warrant further investigation into the efficacy of targeting CypD 
in SCI.  However, we provided some promising preliminary data showing another 
potential target for attenuating secondary spinal cord damage.  We assessed the 
role CAPN5, a member of the calpain family, in spinal cord pathology.  The 
results from our study showed that CAPN5 deficient mice had greater recovery in 
motor function following a severe spinal contusion.  CAPN5 was previously 
shown to be ubiquitously expressed in the rat brain and spinal cord and that it 
has Ca2+ binding domains.  Thus, CAPN5 may have similar proteolytic activity as 
other typical mammalian calpains.  Studies have shown that inhibiting calpain 
can attenuate some of the pathological damage following SCI and TBI.  Thus, 
identifying calpain members that contribute to secondary cell death is critical.  
Our results suggest that CAPN5 may have a physiological role in spinal cord 
injury.  Strategies aimed at multiple calpain isoforms may offer critical protection 
following spinal cord and brain injury.  
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Appendix I 
Effects of NIM811 on Motor recovery in the Mouse Model of Spinal Cord 
Injury 
 
A prominent mechanism of secondary tissue degradation is an increase in 
mitochondrial permeability to any molecules < 1500 Daltons (Hunter et al. 1976; 
Al-Nasser et al. 1986).  This increase in mitochondrial permeability can lead to 
massive swelling and disruption of the mitochondrial membrane, uncoupling of 
oxidative phosphorylation in the electron transport chain and subsequent down 
regulation of ATP production (Hunter et al. 1976; Bernardi et al. 1996; Crompton 
1999; Halestrap et al. 2002).   
Introduction 
Ultimately, it is the formation of the mitochondrial permeability transitional 
pore (mPTP) that permits excessive ion permeability and disruption of 
mitochondrial bioenergetics (Hunter et al. 1976; Al-Nasser et al. 1986).  A critical 
finding by Crompton and colleagues was the inhibition of Ca2+ dependent mPTP 
opening by the immunosuppressive drug cyclosporine A (CsA)(1988).  CsA 
mediates its actions by binding to and inhibiting the mitochondrial matrix 
component cyclophilin D(CypD) from binding to ANT (Crompton et al. 1998).  
CsA inhibited pore formation and subsequent mitochondrial permeability, 
prompting the hypothesis that CypD is the regulating component in mPTP 
formation.   
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CypD has since shown promise as a viable target for protection in rodent 
models of TBI (Sullivan et al. 2000; Mbye et al. 2008).  However, in rodent 
models of SCI, CsA failed to offer any protection unless administered at highly 
toxic doses (Rabchevsky et al. 2001; Morota et al. 2007).   Recently, a CsA 
analog called NIM811 did show some modest protection at the cellular level and 
in functional outcome in rat models of SCI (McEwen et al. 2007; Ravikumar et al. 
2007).  These contradictory results raise uncertainty about the role of CypD in 
SCI pathology. 
We recently showed that mice with a homozygous knockout of Ppif, the 
CypD encoding gene, had no improvements in functional or pathological 
outcomes following SCI.  These findings suggest that CypD has only a minor role 
in secondary spinal cord injury.  Thus, the protective effects from NIM811 
following SCI may stem from additional protein interactions that induce mPTP 
formation independent of CypD.   
It is also feasible that there are additional variations in secondary injury 
response, including mPTP formation and function, between the mouse and rat 
model of SCI.  Thus, a comparison between models is critical for translation of 
protective strategies across models.   In this study, we administered NIM811 to 
wild type (WT) mice following a moderate spinal contusion.  We then utilized the 
Basso mouse scale to assess any improvements in motor function recovery.      
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Animals.  All animals were housed in the Division of Laboratory Animal 
Resources sector of the University of Kentucky Medical Center, which is fully 
accredited by AAALAC. All experimental procedures abide by protocols approved 
by the University of Kentucky's Institutional Animal Care and Use Committee.  
These studies were performed using B6129 female mice purchased from 
Taconic.   
Methods 
Mouse Model of Traumatic Spinal Cord Injury. All experimental procedures were 
conducted in accordance with the guidelines of the Institutional Animal Care and 
Use Committee (IACUC) of the University of Kentucky.  The spinal contusions 
administered in these studies were conducted using the commercially available 
Infinite Horizon (IH) spinal cord injury device (Precision Systems & 
Instrumentation (PSI), Lexington, KY).  The IH impactor allows for user defined 
parameters to achieve the desired severity of injury.  There are three parameters 
measured by the IH impactor and defined as follows: Force as the actual force 
delivered by the impactor compared to the calibrated force, 2. Velocity as the 
speed of the impactor tip as it delivers the contusion, and 3. Displacement as the 
elasticity of the spinal cord required until the calibrated force is achieved. The 
force of the contusion, measured in kilodyns, was calibrated according to each 
severity.  For the severe contusions, a calibrated force of 70kdyn was used. 
These settings were derived from a previous study characterizing injury gradients 
in the mouse model (Basso et al. 2006).  Mice were anesthetized by an 
intraperitoneal injection ketamine(mg/kg) and xylamine(mg/kg).  Laminectomies 
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were made to expose the T10 vertebral segment.  Two clamps were applied 
approximately at the caudal T11 segment and the rostral T9 segment. The spinal 
cord was then lowered and straightened until parallel with the platform.  Sham 
animals received a laminectomy only. Following surgery, all animals were placed 
on a heating pad set at 37°C until consciousness and mobility (upper limbs) was 
regained.  Postoperative care included the manual expression of bladders twice 
daily until recovery of bladder function, injection with 10 ml sterile saline 
administered subcutaneously (s.c.) immediately after surgery, 33.3 mg/kg 
cefazolin, administered by intramuscular injection, twice a day for 1 week then 
once a day for the remaining 3 weeks. 
Experimental Group and Design.  NIM811was generously provided by Dr. Patrick 
Sullivan from the University of Kentucky.   NIM811 (10mg/kg) was made in a 
solution of polyethylene glycol/ .9% sterile saline/cremaphor oil.  The vehicle for 
NIM811 was the polyethylene glycol/sterile saline/cremaphor oil solution only.  
Either NIM811 or vehicle was administered by an intraperitoneally injection at 15 
minutes post surgery/injury and another injection 24 hours post surgery/injury.   
These experiments involved four groups of mice.  Shams with NIM811 2 received 
a laminecotmy and NIM811.  Shams with vehicle received a laminectomy and 
equal volumes of the vehicle.  Injured with NIM811 received a moderate spinal 
contusion and NIM811, and injured with vehicle received a moderate spinal 
contusion and equal volumes of the vehicle.   The dose of NIM811 was selected 
based on a previous study showing the e optimal doses for attenuating  
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mitochondrial dysfunction in mice subjected to cortical contusion (Mbye et al. 
2008). 
Hind Limb Motor Function Assessment.  Motor function following spinal cord 
injury was measured by two raters blinded to the experimental conditions.  Hind 
limb motor function was measured using the Basso Mouse Scale (BMS), a 9 
point categorical scale that rates seven observable motor functions and motor 
deficits.   The seven categories in the BMS included ankle extension, of hind limb 
joint movements, trunk stability, stepping coordination, paw placement, and tail 
position (Basso et al. 2006). A single score was recorded for the left and right 
hind limb which was then averaged to give a total score.  An 11 point subscore 
was obtained to assess subtle variations within each category.  Each BMS test 
was assessed by two examiners. One examiner is the main observer while the 
other examiner observes and records the scores during the exam.  This is to 
ensure that one person is observing the test for the entire duration.  Each trial is 
4 minutes.   
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The Basso Mouse Scale (BMS) analysis was used to assess open field 
motor function in WT mice following moderate spinal contusion.  Mice were 
administered either NIM811 or vehicle at 15 minutes and 24 hours post injury.  
Immediately following spinal impact, both animals displayed complete bilateral 
hind limb paralysis as evident by ankle extension or only ankle extension plus 
plantar placement without weight support (data not shown).   
Results 
Figure10A shows that following moderate SCI, mice administered NIM811 
had significantly greater improvement in functional motor recovery at the 2rd week 
post injury compared to mice administered vehicle only [F=54.28(391.6,162); 
p<.01].  BMS subscores revealed additional time points of increased motor 
recovery (Figure 10B).  Mice administered NIM811 showed significant 
improvements in functional motor recovery at both the 2nd and 3rd week post 
injury (Figure 10B)[F=58.51(372,173.8), p<.01 at 2wk, p<.05 at 3wk].  The 
improved motor recovery at these time points is most likely due to paw 
positioning upon stepping and landing.  Mice receiving NIM811 maintained 
parallel paw positioning throughout the entire step.  This motor skill was not 
observed in mice receiving a vehicle until the 4th week.   
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Figure 10  Basso Mouse Scale(BMS) scores and subscores for WT vehicle and 
NIM811 sham and injured mice at 3d, 1wk, 2wk, 3wk, and 4wk post moderate 
injury.  A. Mice receiving NIM811 showed significant improvement in BMS scores 
at 2 weeks following moderate SCI [**p<.01, F=54.28(391.6,162)].  B. Mice 
receiving NIM811 showed significant improvement in BMS subscores at 2 weeks 
and 3 weeks following moderate SCI [**p<.01 at 2 weeks; *p<.05 at 3 weeks,  
F=58.51(372,173.8)].  Values = Mean +/- STDEV. Two-way ANOVA and 
Bonferroni post hoc test. N=4-5 for injury and sham groups.  
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The principle finding in this preliminary study was that NIM811 
administered to WT mice following moderate SCI significantly improves motor 
function.  The purpose of this study was to assess the protective effects of 
NIM811 in a mouse model of SCI.  Previous studies have produced confounding 
results when administering CypD inhibitors in rat models of SCI (Rabchevsky et 
al. 2001) 
Discussion and Conclusion 
Although NIM811-treated mice showed improvements in motor recovery at 
two weeks and three weeks following moderate spinal contusion, the 
improvements observed were very modest.  Further assessment of tissue 
sparing and cellular alterations is needed to further characterize the protective 
mechanism of NIM811.  Still, these preliminary data provide a critical finding in 
that NIM811 has protective effects in mice and rats.  This may allow for more 
confident translation and interpretation of results across both mouse and rat 
models of SCI.   
 There is still uncertainty if CypD is exclusively targeted by NIM811, at 
least in the mouse model.  Previously we showed that CypD null mice had no 
greater improvements in functional or pathological outcomes following SCI.  
Future studies are needed to examine the effects of NIM811 in CypD-null mice.  
If NIM811 does improve spinal cord injury outcome in CypD-null mice, this would 
suggest that NIM811 targets additional proteins involved in secondary spinal cord 
other than CypD.  
Copyright © Jordan Clark 2009 
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Appendix II 
Role of Calpain 5 in Spinal Cord Injury 
 
Calpains are Ca2+ dependent cysteine proteases involved in several 
cellular functions including cell motility, synaptic remodeling, embryonic 
development and (Luscher et al. 2000; Liu et al. 2008).  To date,  approximately 
14 mammalian calpain isoforms have been identified (Goll et al. 2003).  Typical 
calpain isoforms, µ-calpain and m-calpain, are ubiquitously expressed while 
atypical isoforms are tissue specific (Goll et al. 2003).  Typical mammalian 
calpains generally consist of a large distinctive catalytic subunit and a small 
common regulatory subunit (Goll et al. 2003).  Several proteins are substrates for 
calpain such as cytoskeletal structural and cell motility proteins (Posmantur et al. 
1994; Pang et al. 1996; Azam et al. 2001). 
Introduction 
 Hyper activation of calpain has been implemented in pathological events, 
specifically secondary cellular degradation following traumatic brain injury (TBI) 
and spinal cord injury (SCI) (Banik et al. 1982; Saido et al. 1994; Huang et al. 
2001).(Huang et al. 2001) Several studies have shown that pharmacological 
inhibition of calpain attenuates motor deficits and tissue degradation in rodent 
models of TBI and SCI  (Springer et al. 1997; Ray et al. 1999; Schumacher et al. 
2000; Deng et al. 2007).  Thus, there has been an extensive effort to identify 
additional calpains potentially involved in the pathology of TBI and SCI. 
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 Previously, calpain-5 (CAPN5) was cloned and characterized in rats and 
found to have a highly homologous sequence to both human and mice (Matena 
et al. 1998; Waghray et al. 2004).  In rats and humans, CAPN5 was shown to be 
ubiquitously expressed in several brain regions including the medulla oblongata, 
hypothalamus, thalamus, cerebellum, and frontal lobe (Waghray et al. 2004).  In 
addition, CAPN5 was shown to have key calcium binding domains similar to the 
typical calcium dependent calpains.  These characteristics suggest that CAPN5 
may be involved in neurological injury.  To assess the potential involvement of 
CAPN5 in SCI, we administered a severe spinal contusion to CAPN5-/+ mice.  
Our results suggest that CAPN5 may be a key calpain isoform that exacerbates 
functional outcome in spinal injury.    
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Animals.  All animals were housed in the Division of Laboratory Animal 
Resources sector of the University of Kentucky Medical Center, which is fully 
accredited by AAALAC. All experimental procedures abide by protocols approved 
by the University of Kentucky's Institutional Animal Care and Use Committee.  
Mice with a heterozygous knockout of CAPN5 (Capn5tm1Dgen) were purchased 
from the Jackson laboratory.  The WT mice utilized were B6129 purchased from 
Taconic. 
Methods 
Mouse Model of Traumatic Spinal Cord Injury. All experimental procedures were 
conducted in accordance with the guidelines of the Institutional Animal Care and 
Use Committee (IACUC) of the University of Kentucky.  The spinal contusions 
administered in these studies were conducted using the commercially available 
Infinite Horizon (IH) spinal cord injury device (Precision Systems & 
Instrumentation (PSI), Lexington, KY).  The IH impactor allows for user defined 
parameters to achieve the desired severity of injury.  There are three parameters 
measured by the IH impactor and defined as follows: Force as the actual force 
delivered by the impactor compared to the calibrated force, 2. Velocity as the 
speed of the impactor tip as it delivers the contusion, and 3. Displacement as the 
elasticity of the spinal cord required until the calibrated force is achieved. The 
force of the contusion, measured in kilodyns, was calibrated according to each 
severity.  For the severe contusions, a calibrated force of 70kdyn was used. 
These settings were derived from a previous study characterizing injury gradients 
in the mouse model (Basso et al. 2006).  Mice were anesthetized by an 
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intraperitoneal injection ketamine(mg/kg) and xylamine(mg/kg).  Laminectomies 
were made to expose the T10 vertebral segment.  Two clamps were applied 
approximately at the caudal T11 segment and the rostral T9 segment. The spinal 
cord was then lowered and straightened until parallel with the platform.  Sham 
animals received a laminectomy only. Following surgery, all animals were placed 
on a heating pad set at 37°C until consciousness and mobility (upper limbs) was 
regained.  Postoperative care included the manual expression of bladders twice 
daily until recovery of bladder function, injection with 10 ml sterile saline 
administered subcutaneously (s.c.) immediately after surgery, 33.3 mg/kg 
cefazolin, administered by intramuscular injection, twice a day for 1 week then 
once a day for the remaining 3 weeks. 
Hind Limb Motor Function Assessment.  Motor function following spinal cord 
injury was measured by two raters blinded to the experimental conditions.  Hind 
limb motor function was measured using the Basso Mouse Scale (BMS), a 9 
point categorical scale that rates seven observable motor functions and motor 
deficits.   The seven categories in the BMS included ankle extension, of hind limb 
joint movements, trunk stability, stepping coordination, paw placement, and tail 
position (Basso et al. 2006). A single score was recorded for the left and right 
hind limb which was then averaged to give a total score.  An 11 point subscore 
was obtained to assess subtle variations within each category.  Each BMS test 
was assessed by two examiners. One examiner is the main observer while the 
other examiner observes and records the scores during the exam.  This is to 
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ensure that one person is observing the test for the entire duration.  Each trial is 
4 minutes.   
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The Basso Mouse Scale (BMS) analysis was used to assess CAPN5+/- 
and WT mice for open field motor function following severe spinal contusion.  
Immediately following spinal impact, both animals displayed complete bilateral 
hind limb paralysis as evident by ankle extension or only ankle extension plus 
plantar placement without weight support (data not shown).   
Results 
Figure 11A. and B show that following severe SCI, CAPN5+/- mice had a 
significantly greater improvement in functional motor recovery at the 2rd week 
post injury [F=17.28(337.2,48.65); p<.01]. CAPN5+/- mice showed recovery of 
some coordination, occasional to consistent stepping, and only mild trunk 
stability.  While WT did eventually achieve the same level of motor recovery, this 
wasn’t observed until the 3rd and 4th week, as shown by BMS subscores (Figure 
9B)[F=7.861(256.2,18.03), p<.001].     
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Figure 11 Basso Mouse Scale(BMS) scores and subscores for WT and CAP5+/-  
sham and injured mice at 3d, 1wk, 2wk, 3wk, and 4wk post severe injury.  A-B. 
CAP5+/-l injured mice showed significant improvement in BMS scores and 
subscores compared to WT injured mice at 2 weeks following severe SCI. 
Values=Mean +/- STDEV. **p<.01, F=17.28(337.2,48.65); ***p<.001, 
F=7.861(256.2,18.03). Two-way ANOVA and Bonferroni post hoc test. N=4-5 for 
injury and sham groups.  
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The results from this study show that CAPN5-/+ mice have improved 
functional motor recovery following severe spinal cord contusion.  Little is known 
about the physiological function of CAPN5-/+ in mice.  However, calpains have 
been implicated in the pathology of spinal cord injury (Banik et al. 1982; Banik et 
al. 1998; Ray et al. 1999).  Following spinal contusion, calpain can remain 
elevated for days and weeks.  Hyper activation of Calpain degrades several 
cellular proteins leading to both necrotic and apoptotic mechanisms of death 
(Ray et al. 1999).  Substantial evidence has shown calpain to be a promising 
target for neurological protection following SCI.  Previous studies using calpain 
inhibitors of calpain demonstrated decreased cellular protein degradation, 
increased tissue sparing and improved motor function in rat models of SCI 
(Springer et al. 1997; Zhang et al. 2003; Yu et al. 2007). 
Discussion 
 Here we show that CAPN-5 may also have a role in spinal cord pathology.  
Motor recovery was improved in CAPN5-/+ mice at the second week following 
severe spinal cord injury.  WT mice at this time point had regained only 
occasional stepping with some weight support.  CAPN5-/+ , however, showed 
frequent stepping with full weight support, followed by recovery of some 
coordination.  Both models achieved the same level of recovery by the 4thweek. 
These motor skills included consistent weight bearing and stepping, coordination, 
and mild trunk stability. Though, CAPN5-/+ mice recovered these motor skills at 
an earlier time point, it did not continue to display improved function.   
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Recently, CAPN5 was shown to be ubiquitously expressed in the rat brain 
and spinal cord (Waghray et al. 2004). Further characterization showed CAPN5 
contained key Ca2+ binding domains (Wagner et al. 1999).  These properties of 
CAPN5 may reveal a protease function similar to µ and m-calpain.  This recent 
characterization and localization of CAPN5, along with our findings of motor 
improvements in CAPN5-/+ mice, suggest that CAPN5 may have a critical role in 
spinal cord pathology.   It is important to note that we utilized mice with a 
heterozygous knockout of CAPN5. This is because homozygous knockouts are 
embryonic lethal.  Despite only partial ablation of CAPN5, we still observed 
functional improvements.  Thus, multiple strategies using potent CAPN5-specifc 
inhibitors in conjunction with other calpain inhibitors may greatly improve 
functional and pathological recovery in spinal injury.    
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Appendix III 
Glossary of Important Terms 
AIF                apoptosis inducing     
 factor 
AMPA α-amino-3-hydroxy-5-
methyl-4-
isoxazolepropionic acid 
ANT adenine nucleotide 
translocase 
ATP               adenosine  triphos  
            -phate 
BMS              Basso Mouse Scale 
CsA  cyclosporine A 
CypD  cyclophilin D 
CypD-null cylophilin D 
homozygous knockout                 
MAP-2 microtubule-associated 
protein 
mPT           mitochondrial 
permeability 
mPTP         mitochondrial 
permeability transitional 
pore 
NMDA N-Methyl-D-aspartate 
PPIase peptidyl-prolyl-cis-trans-
isomerase 
ROS reactive oxygen species 
SBP spectrin breakdown 
product 
SCI spinal cord injury 
TBI traumatic brain injury 
VDAC voltage dependent 
anionic channel 
WT wild type 
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